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“Let us try to teach generosity and altruism, because we are born selfish. 
Let us understand what our own selfish genes are up to, because we may then at least have the 
chance to upset their designs, something that no other species has ever aspired to.” 
(Richard Dawkins)
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Abbreviations 
 
5caC 5-carboxymethylcytosine 
5fC 5-formylmethylcytosine 
5hmC 5-hydroxymethylcytosine 
5hmU 5-hydroxymethyluridine 
5mC 5-methylcytosine 
AD Alzheimer‘s disease 
AID activation induced cytidine deaminase 
ALS Amyotrophic lateral sclerosis 
APOBEC apolipoprotein B mRNA editing enzyme, catalytic  
APS Ammonium persulfate 
BER base excision repair 
BHT 2, 6-di-tert-butyl-4-methyl-hydroxytoluene 
bp base pairs 
BRD bromodomain 
C cytosine 
CARM1 co-activator arginine methyltransferase 
CD chromodomain 
ddH20 double deionized water 
desferal deferoxamine mesylate salt 
DNA desoxyribonucleic acid 
DNMT DNA methyltransferase 
e.g. exempli gratia 
ESC embryonic stem cells 
ENCODE Encyclopedia of DNA Elements 
et al. et alii 
GCL ganglion cell layer 
GFP green fluorescent protein 
h hour 
H1-4 histone 1-4 
HAT histone acetyltransferase 
HCl hydrochloric acid 
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HDAC histone deactylase 
HDM histone demethylase 
HEK293T human embryonic kidney cells  
HGP Human Genome Project 
HMT histone methyltransferase 
i.e. id est 
INL inner nuclear layer 
IP immunoprecipitation 
K lysine 
kDa kilodalton 
LC liquid-chromatography 
LFQ label-free quantification 
me monomethylation  
me2 dimethylation 
me3 trimethylation 
mg milligram 
min minute 
ml milliliter 
MBD methyl-CpG binding protein 
MS mass spectrometry 
NHGRI National Human Genome Research Institute 
NIH National Institutes of Health 
nm nanometer 
O-GlcNAc O-glucosyl-N-acetylation 
OGT O-GlcNAc transferase 
ONL outer nuclear layer 
p postnatal day 
PAGE  polyacrylamide gel electrophoresis 
PB phosphate buffer 
PBS phosphate buffer saline 
PCR polymerase chain reaction 
PHD plant homodomain 
PLA proximity ligation assay 
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Pol II polymerase II 
PRC2 polycomb repressive complex 2 
PRMT protein arginine N-methyltransferase 
ptm posttranslational modification 
R arginine 
RNA ribonucleic acid 
s  seconds 
SAM S-adenosyl-methionine 
SD standard deviation 
SDS sodium dodecyl sulfate 
SEM standard error of the mean 
SET su(var)3-9, Enhancer-of-zeste and Trithorax 
SMUG1 single-strand selective monofunctional uracil-DNA glycosylase 
T thymine 
TDG thymine DNA glycosylase 
TET ten-eleven translocation 
TEMED tetramethylethylenediamine 
THU deaminase inhibitor tetrahydrouridine 
TSS transcriptional start site 
TTS transcriptional termination site 
µg microgram 
µm micrometer 
WHSC1L1/NSD3 Wolf-Hirschhorn syndrome candidate 1-like 1 
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1. Introduction 
 
1.1 Background 
 
“So that I may perceive whatever holds, the world together in its inmost folds. See all its 
seeds, its working power, and cease word-threshing from this hour.” is a quote by the 
German poet Johannes Wolfgang Goethe describing his protagonist’s desire of gaining 
more knowledge. Echoing these sentiments the US government announced their research 
plan "The Human Genome Project" in 1990 to understand our genetic inheritance. Several 
years later the Human Genome Project (HGP) declared that the human genome containing 
3.2 billion DNA base pairs was fully sequenced and all human genes had been identified 
(Lander et al., 2001). Importantly, the HGP revealed that people are 99.9 % identical at 
the DNA level. Although this was a scientific breakthrough, the difference of 0.1 % in 
DNA sequence alone was not able to explain the inter-individual differences.  
Moreover, the human body contains more than 200 different cell types i.e. heart cells or 
liver cells that share an identical DNA sequence, display different phenotypes (Surani, 
2001). These different phenotypes include a unique cellular identity formed by tissue-and 
stage-specific gene expression. The changes in gene expression must be controlled and 
interpreted by mechanisms independent of the genetic code due to the identical DNA 
sequence.  
Conrad Hal Waddington explained this discrepancy by introducing the term epigenotype 
referring to it as a complex interplay of genes and environment that modulate a genotype 
to a particular phenotype (Waddington, 2012). Waddington used the analogy of a marble 
on a hill to describe the epigenetic landscape. During the process of differentiation from 
a germ cell to a specialized cell type the epigenetic landscape decides which specific cell 
type is formed by ridges and valleys that branch at different points. As the marble rolls 
downhill, the possible paths are progressively narrowed, and by the time it reaches the 
valley, it becomes a differentiated cell (Figure 1). 
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Figure 1. The epigenetic landscape by Conrad Waddington. 
The process of cellular differentiation can be compared to a marble on a hill that represents a 
pluripotent cell state. The hill contains different paths that the marble can roll down and each path 
will eventually lead to a distinct final differentiated cell type i.e. a heart cell, liver cell, kidney cell 
and brain cell. During the process of differentiation the amount of alternative paths are limited by 
epigenetic modifications resulting in a loss of pluripotency and terminal differentiation. Adapted 
from (Barth and Imhof, 2010). 
 
The main components of this epigenetic landscape involve modifications of histone pro-
teins, ribonucleic acid (RNA), mediated gene silencing and the covalent modification of 
DNA bases. All of these modifications can alter the accessibility of genes and subse-
quently control gene expression (Jaenisch and Bird, 2003). Epigenetic mechanisms are 
important key regulators in development and disease. Defects in epigenetic regulation are 
involved in different diseases including neurodegenerative disorders i.e. Autism, Alz-
heimer’s disease, cancer, obesity and mental retardation (Egger et al., 2004; Portela and 
Esteller, 2010). In reference to the genetic code the concept of a histone or epigenetic 
code was established (Jenuwein and Allis, 2001; Turner, 2000). Based on the HGP the 
Encyclopedia of DNA Elements (ENCODE) project was launched to study functional 
elements i.e. mapping epigenetic modifications within the human genome by the National 
Human Genome Research Institute (NHGRI) in 2003. Although, this project had signifi-
cant impact for human genetics studies, a major drawback was that most of the findings 
relied on a limited amount of cultured human cell lines. Thus, a new project called the 
Roadmap Epigenomics Project launched by the US National Institutes of Health (NIH) 
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investigates epigenomic data directly from different human cells, e.g. stem cells and dif-
ferentiated cells derived from healthy and diseased people.  
 
 
 
1.2 The nucleosome 
 
The nucleosome is a basic repetitive structuring unit of DNA that is present in all eukar-
yotic chromosomes and an important factor for DNA accessibility (Jiang and Pugh, 2009) 
(Figure 2). It consists of 200 ± 40 base pairs of DNA and a highly conserved basic protein 
octamer that consists of two copies of the core histone (H) protein dimers H2A/H2B and 
H3/H4 forming a negative supercoiling and has a molecular weight of 206 kilo Dalton 
(kDa) (Richmond and Davey, 2003). The core histone proteins consist of an N-terminal- 
a globular- and a C-terminal domain. The protruding histone N-terminal tails (histone 
tails), and to a lower degree the C-terminal regions, can be altered by a variety of enzyme-
catalyzed, posttranslational modifications known as histone modifications (Richmond 
and Davey, 2003). These modifications are necessary for higher order chromatin structure 
and intranucleosomal and internucleosomal interactions. 
 
Figure 2. The nucleosome core structure. 
(A) The nucleosome viewed down the superhelical axis. Histones H2A, H2B, H3, and H4 are 
shown in yellow, red, blue, and green, respectively. (B) Viewed as in panel (A) but rotated around 
the y axis by 90°. Adapted from (Andrews and Luger, 2011). 
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The nucleosome contains two different DNA components. The nucleosomal core particle 
consists of 146 base pairs of DNA that are wrapped in 1.67 superhelical turns around the 
histone octamer (Luger et al., 1997). The nucleosomal DNA is present in a "beads-on-a-
string"-like structure, a 10 nm fiber, where the nucleosomes represent the beads and the 
DNA the string (Olins and Olins, 1974; van Holde and Zlatanova, 1996).  The "linker 
DNA" is linear DNA present between histone octamers. It varies in a tissue- and species-
specific manner from 20 – 90 base pairs.  
Due to the presence of a linker histone H1 the nucleosome can be further compacted to a 
30 nm fiber (Richmond and Davey, 2003) (Figure 3A-B). Further compaction of the chro-
matin is triggered by scaffold proteins that result in the formation of chromosomes (Arold 
et al., 2010).  
 
Figure 3. Schematic view of a nucleosome. 
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1.3 The epigenetic code 
The nucleosome that encrypts the epigenetic code has divergent functions. On the one 
hand, it has to stabilize, package and protect the DNA. On the other hand, the nucleosome 
has to be flexible and dynamic in order to allow access for polymerases to transcribe and 
replicate. One of the main mechanisms to modify nucleosomes are epigenetic modifica-
tions such as the covalent deposition of a methyl group to the DNA base cytosine for 
transcriptional silencing (Razin, 1998). Another mechanism to allow changes in DNA 
accessibility is the replacement of canonical histones with specialized histone variants. 
The incorporation of these histone variants leads to major changes in chromatin structure, 
thus influencing transcription and genome stability (Ahmad and Henikoff, 2002). Fur-
thermore, the establishment of posttranslational modifications on the histone tails of core 
histone proteins is essential for transcriptional regulation (Allfrey et al., 1964). Among 
the best-characterized histone modifications are small chemical moieties such as methyl-
ation, phosphorylation and acetylation of specific amino acid residues (Figure 4). These 
modifications are established, respectively, by specific enzymes called histone writers, 
i.e. histone methyltransferases (HMT), kinases and histone acetyltransferases (HAT) at 
specific amino acid residues. Furthermore, ADP-ribosylation, biotinylation, O-Glucose-
N-Acylation (O-GlcNAc), SUMOylation, and ubiquitinylation can occur on histone tails 
to modify the nucleosomal architecture (Zhou et al., 2011).  
 
Figure 4. Most common histone modifications of core histones. 
Schematic view of N-terminal histone modifications on the four canonical histones H2A, H2B, 
H3, H4. The covalent posttranslational modifications such as methylation (Me), acetylation (Ac), 
phosphorylation (P) of distinct amino acid residues are highlighted on the N- terminal tails of 
each histone.  
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The methylation of histones was discovered more than 40 years ago. It involves the ac-
tivity of histone methyltransferases and requires S-adenosyl-methionine (SAM) for its 
catalytic activity (Murray, 1964). Histone methylation is essential for transcriptional reg-
ulation and can occur in different forms such as mono-, di-, and trimethylation of lysine 
(K) or mono- and dimethylation of arginine (R) residues. Histone 3 (H3) can be methyl-
ated at various K residues i.e. K4, K9, K27, K36, K79 and R residues i.e. R2, R8, R17 
and R26. K methylation is mainly generated by SET domain containing proteins such as 
EZH1-2, SET1 and NSD3, whereas R methylation is carried out by co-activator arginine 
methyltransferase (CARM1) and protein arginine methyl transferases (PRMT) (Bannister 
et al., 2002; Chen et al., 2011; Dillon et al., 2005).  
Histone methylation leads to transcriptional activation or repression depending on the 
position of the amino acid residue and the degree of methylation.  In eukaryotes the meth-
ylation of K at position 4 and 36 of the histone 3 (H3) is associated with transcriptional 
initiation and elongation leading to active gene transcription. Di (me2)- and trimethyla-
tion (me3) of H3K4 is predominantly present around transcriptional start site (TSS) of 
promoter regions and is formed by HMTs such as SETD1A/B and MLL, whereas 
H3K36me2/3 is established within gene bodies by HMTs such as SETD2 and NSD1-3 
(Ruthenburg et al., 2007; Schmidt and Jackson, 2013; Wysocka et al., 2005). In contrast 
to this "activating" histone methylation marks, the di- and trimethylation of H3K27 or 
H3K9 is associated with transcriptional repression (Mikkelsen et al., 2007). H3K27 tri-
methylation is generated in promoter regions by EZH2, a member of the polycomb re-
pressive complex 2 (PRC2) (Cao and Zhang, 2004). Interestingly, H3K27me3 can co-
exist with H3K4me3 leading to poised gene transcription of developmental genes 
(Bernstein et al., 2006).   
Histone methylation was thought to be irreversible until the first histone demethylase 
(HDM) KDM1A was discovered that demethylates H3K4 and H3K9 mono- and demeth-
ylation (Shi et al., 2004). Two different mechanisms for demethylation exist: a flavin 
adenine dinucleotide (FAD)-dependent amine oxidation by HDMs such as KDM1A, and 
an Fe(II) and α-ketoglutarate-dependent dioxygenation by KDM4A and similar HDMs 
(Hino et al., 2012; Tsukada et al., 2006). 
Most of the histone modifications are reversible and can be removed by enzymes known 
as histone erasers, e.g. histone deacetylases (HDACs) that remove histone acetylations 
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(Jakovcevski and Akbarian, 2012). Around 240 amino acid residues within a nucleosome 
are available for histone modifications. This allows a vast combination of different his-
tone modifications leading to changes in DNA accessibility and recruitment of non-his-
tone proteins known as histone readers. These histone readers contain binding domains 
that allow for specific binding to distinct histone modifications (Figure 5). For example 
histone methylation is recognized by chromodomains (CD) and non-related plant homeo 
domains (PHDs), whereas acetylation is recognized by bromodomains (BRD) (Nielsen et 
al., 2002; Zeng et al., 2010). There are different mechanisms allowing histone readers to 
act on histone modifications. First they can bind their target histone modification and 
directly condense or decondense the underlying chromatin (Verdin and Ott, 2015). Fur-
thermore, a reader can associate with histone writers to form a multiprotein complex and 
introduce additional modifications to the nucleosome (Musselman et al., 2012). In con-
clusion the interplay of histone readers, writers and erasers enable a complex coding ma-
chinery of the nuclosomal environment (Figure 5).  
 
Figure 5. Epigenetic readers, writers and erasers. 
Epigenetic writers e.g. histone acetyltransferases (HATs), histone methyltransferases (HMTs), 
protein arginine methyltransferases (PRMTs) and kinases establish defined modifications on spe-
cific histone tail amino acid residues. Epigenetic readers e.g. bromodomain or chromodomain 
containing enzymes recognize and bind specific histone modifications. Epigenetic erasers e.g. 
histone deacetylases (HDACs), lysine demethylases (KDMs) and phosphatases remove histone 
modifications.  
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1.4  DNA methylation 
DNA methylation usually refers to the covalent addition of a methyl group at the 5-carbon 
of the cytosine base yielding 5-methylcytosine (5mC) (Figure 6A). The deposition of me-
thyl groups on cytosines is an important epigenetic mechanism for repression of gene 
expression that is involved in processes such as embryonic development, genomic im-
printing, X-chromosome inactivation and preservation of chromosome stability (Boyes 
and Bird, 1991). DNA methylation is controlled by a family of enzymes known as DNA 
methyltransferases (DNMTs). Three different DNMTs (DNMT1, DNMT3A and 
DNMT3B) are involved in the maintenance and establishment of DNA methylation pat-
terns. Another member of this family called DNMT3L, lacking methyltransferase activ-
ity, stimulates methylation by recruitment of DNMT3A and DNMT3B (Chedin et al., 
2002; Pacaud et al., 2014). In contrast, DNMT1 is recruited by its obligate partner UHRF1 
for the maintenance of DNA methylation during cell division. UHRF1 binds to hemi-
methylated CG sites and recruits DNMT1 leading to methylation of the nascent DNA 
strand to maintain DNA methylation patterns through cell division (Liu et al., 2013b) 
(Figure 6B). In contrast to DNMT1, DNMT3A and DNMT3B are involved in de 
novo  methylation of DNA (Okano et al., 1999) (Figure 6C). However, the mechanisms 
directing de novo DNMT enzymes to their respective sites are not well understood. 
 
Figure 6. DNA methylation by maintenance and de novo DNMT enzymes. 
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(A) DNA methylation occurs at cytosine bases when a methyl group (-CH3) from the co-factor S-
adenosyl methionine (SAM) transferred to the position 5 of the pyrimidine ring by DNMT1 and 
DNMT3A/B. (B) The maintenance methyltransferase DNMT1 methylates hemi-methylated DNA 
at the complementary strand. (C) The de novo methyltransferases DNMT3A and DNMT3B ini-
tiate de novo methylation of previously nonmethylated cytosines. 
 
Several studies have shown that methylation within a promoter region is able to recruit 
methyl-CpG-binding domain proteins (MBPs), which then prevent binding of transcrip-
tion factors and, thus, inhibit gene transcription (Boyes and Bird, 1991; Gu et al., 2011). 
Subsequently, these MBPs are able to recruit histone modifying enzymes (Tan and 
Nakielny, 2006). These ATP-dependent enzymes lead to chromatin compaction and fur-
ther transcriptional repression by altering chromatin accessibility.  
Vertebrates and plants have conserved DNA methylation machinery. However, the DNA 
demethylation machinery is different. Plants possess the DNA glycosylases repressor of 
silencing (ROS1) and Demeter (DME). These glycosylases can excise 5mC and the 
abasic site is replaced by an unmethylated cytosine via base excision repair (BER) (Choi 
et al., 2002; Gong et al., 2002). However, such enzymes are not present in vertebrates. A 
potential mechanism to remove the 5mC mark in vertebrates is passive DNA demethyla-
tion, also known as replication-dependent demethylation. Passive 5mC removal can occur 
by dilution of symmetrically-methylated regions by inactivation or absence of the mainte-
nance methyltransferase DNMT1 after DNA replication leading to hemimethylation in 
the daughter cells. Subsequent cell division would lead to subsequent 5mC dilution by 
generating two unmethylated and two hemimethylated daughter cells (Kagiwada et al., 
2013).  
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1.5 TET-mediated 5mC oxidation 
 
A potential candidate for active DNA demethylation is the ten-eleven translocation (TET) 
family of 5mC hydroxylases that can convert 5mC to 5-hydroxymethylcytosine (5hmC) 
(Kriaucionis and Heintz, 2009; Tahiliani et al., 2009). TET proteins belong to the family 
of 2-oxoglutarate and Fe(II)-dependent enzymes and are able to further oxidize 5hmC to 
5-formylcytosine (5fC) and 5-carboxycytosine (5caC) (Tahiliani et al., 2009).  
At least four pathways are imaginable for oxidative DNA demethylation by TET enzymes 
(Figure 7). 5hmC could facilitate passive DNA demethylation by interfering with the 
maintenance methylation. In line with this hypothesis it was shown in vitro that UHRF1 
that recruits DNMT1, binds tenfold less efficient hemi-5hmC DNA compared to hemi-
5mC DNA. This results in a 50-fold reduction of recombinant DNMT1 activity at hemi-
5hmC sites (Hashimoto et al., 2012). Another mechanism of demethylation involves fur-
ther oxidation of 5hmC to 5fC and 5caC by TET enzymes. It was shown that 5fC and 
5caC can be removed by thymidine DNA glycosylase (TDG) leading to replacement of 
the abasic site by BER machinery (He et al., 2011; Maiti and Drohat, 2011). The third 
putative mechanism is the direct decarboxylation of 5caC. It was shown in embryonic 
stem cells (ESC) that direct conversion of 5caC to cytosine can occur without BER 
(Schiesser et al., 2013). However, the enzyme catalyzing this reaction is not yet identified. 
The fourth mechanism is the removal of 5hmC to cytosine by DNMT enzymes under 
oxidizing conditions that was shown to be the case in in vitro experiments (Chen et al., 
2012). However, it is not known if this reaction occurs in vivo. 
 
Introduction 23 
 
 
 
 
Figure 7. Model pathways of active DNA demethylation via oxidation. 
A direct demethylase from 5mC to C was hypothesized but has not yet been identified. The ten-
eleven translocation (TET) family of dioxygenases can oxidize iteratively 5mC to 5-hy-
droxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC). 5fC and 
5caC can be removed by DNA glycosylases coupled with base excision repair (BER). Further-
more, it is possible that a decarboxylase can convert 5caC to C. 
 
Moreover, it was suggested that 5hmC could be deaminated to 5-hydroxyuracil (5hmU) 
via activation induced cytidine deaminase (AID) and apolipoprotein B mRNA editing 
enzyme, catalytic polypeptide (APOBEC). Interestingly, 5hmU could be removed by 
TDG or Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) (Guo 
et al., 2011). Finally, it is possible that 5mC is directly deaminated to thymine by APO-
BEC3A (Wijesinghe and Bhagwat, 2012) (Figure 8). Interestingly, it was recently shown 
that the TET enzymes are also able to oxidize thymine to 5hmU (Pfaffeneder et al., 2014), 
which could also result in BER.  
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Figure 8. Model pathways of active DNA demethylation via deamination. 
5mC and 5hmC can be deaminated by AID/APOBEC deaminases resulting in thymine (T) and 5-
hydroxymethyluracil (5hmU). Furthermore, T can be oxidized by TETs to produce 5hmU and 
both T and 5hmU can be excised by glycosylases coupled to BER.  
 
In summary, TET induced DNA demethylation could occur by facilitation of passive de-
methylation, DNA repair, enzymatic deformylation/decarboxylation and deamination. 
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1.6  The 6th DNA base 5-hydroxymethylcytosine 
 
5hmC is not only a degradation intermediate during active DNA demethylation but is also 
actively involved in gene expression regulation (Hahn et al., 2013; Mellen et al., 2012). 
Thus, in reference to 5mC that is called the 5th DNA base, 5hmC was coined the 6th DNA 
base (Münzel et al., 2010).  
5hmC is abundant in most mammalian tissues, but high levels are present in embryonic 
stem (ES) cells (5-10% relative to 5mC) and the highest levels are found in neurons 
(Globisch et al., 2010; Szulwach et al., 2011). The high abundance of 5hmC in neurons 
suggested that 5hmC is a stable epigenetic DNA base and not a transient DNA demeth-
ylation intermediate in a sequential demethylation process. In line with this, it was shown 
that 5hmC accumulates during neurogenesis (Hahn et al., 2013; Szulwach et al., 2011). 
Interestingly, 5hmC was mainly acquired in promoters and gene bodies of neuronal dif-
ferentiation-related genes and the increase in 5hmC was associated with transcriptional 
activation. Furthermore, a study by Hahn et al. (Hahn et al., 2013) showed that TET3 is 
the most highly expressed TET isoform in the developing mouse brain. This suggests that 
TET3 may play a major role in 5hmC formation. However, how Tet-mediated 5hmC for-
mation is controlled and directed to specific sites is not well understood.  
Mapping experiments have shown that all three TET proteins are strongly enriched at 
CpG-rich promoters (Kohli and Zhang, 2013). It was shown that TET1 and TET3 bind 
unmethylated CpG sequences due to the presence of a CXXC domain (Allen et al., 2006; 
Xu et al., 2012). In line with this finding the distribution of TET proteins and oxidized 
5mC species only overlap partially (Pastor et al., 2013). TET2 lacks such a CXXC do-
main, but was shown to functionally interact with the CXXC domain containing protein 
IDAX (Ko et al., 2013). TET3, the major Tet isoform in neurons (Colquitt et al., 2013; 
Hahn et al., 2013), exists in various isoforms generated by alternative splicing (Liu et al., 
2013a), two isoforms containing a CXXC domain and one shorter isoform lacking such 
a domain. The TET3 isoform lacking a CXXC domain (neuronal TET3) was shown to be 
particularly enriched in neuronal tissue (Liu et al., 2013a). However, the preferential bind-
ing sites of neuronal TET3 and the recruitment to the DNA are not known. It was sug-
gested that transcriptional regulators might bind directly to TET3 thereby facilitating its 
specific targeting to genomic positions and, hence, controlling 5hmC levels (Xu et al., 
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2012). If such a regulation mechanism exists, transcription factor-dependent control of 
TET3 activity could potentially contribute to epigenetic regulation of gene expression in 
neurons. However, transcriptional regulators that functionally interact with TET3 have 
not been identified so far. Different mechanisms of action are possible for 5hmC to act as 
an epigenetic regulator with specific biochemical coding properties. First, 5hmC could 
block or alter binding of 5mC specific binding proteins (readers) such as the family of 
MBD proteins (Pastor et al., 2013). In a reciprocal manner 5hmC could recruit novel 
specific readers such as transcriptional regulators. Recent studies have shown that 
UHRF1, MECP2, MBD3 and the CHTOP-methylosome complex interact with 5hmC in 
vitro (Hashimoto et al., 2012; Mellen et al., 2012; Takai et al., 2014; Yildirim et al., 2011). 
Moreover, a proteomic approach identified several tissue-specific 5hmC readers in ESC, 
neuronal progenitor cells (NPC) and brain (Spruijt et al., 2013). Thus, suggesting that 
5hmC is able to recruit different sets of readers in a tissue-specific manner and thereby 
increasing its spectrum of epigenetic regulation. Interestingly, several studies strongly 
suggest that dysregulation of 5hmC or altered 5hmC binding are implicated in neurolog-
ical disorders (Table 1).  
diseases alteration of 5hmC Reference 
Angelman syndrome global increase  (Szulwach et al., 2011) 
Amyotrophic lateral 
sclerosis (ALS) 
global increase  (Figueroa-Romero et al., 2012) 
Alzheimer's disease 
(AD) 
decrease or increase  (Chouliaras et al., 2013; 
Condliffe et al., 2014; 
Coppieters et al., 2014) 
Autism enrichment on autism related 
genes 
(Khare et al., 2012; Wang et al., 
2012; Zhubi et al., 2014) 
Fragile X syndrome 
(FXS) 
enrichment in FXS related 
genes 
(Wang et al., 2012) 
Huntington's disease 
(HD) 
global decrease (Villar-Menendez et al., 2013; 
Wang et al., 2013) 
Rett syndrome global decrease  (Szulwach et al., 2011) 
Table 1. Neurological disorders associated with alterations of 5hmC levels. 
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1.7 Retinal maturation 
 
The retina is a complex neural network that is necessary for detection, processing and 
transfer of visual information to higher brain regions. It consists of five major classes of 
neurons that are arranged in three cellular layers (Figure 9). Light detection occurs in the 
outer nuclear layer (ONL) that contains rod and cone photoreceptors. Synaptic wiring of 
bipolar cells, horizontal cells and photoreceptors occurs in the outer plexiform layer 
(OPL). The nuclei of bipolar cells, amacrine cells and horizontal cells are in the adjacent 
inner nuclear layer (INL). Next to the INL is the inner plexiform layer (IPL) that harbors 
the synapses of bipolar cells and ganglion cells. The cell bodies of ganglion cells are 
present in the ganglion cell layer (GCL) (Figure 9). It is known that this complex retinal 
network is established in a precisely timed and organized fashion during development 
(Heavner and Pevny, 2012; Kuhrt et al., 2012). However, the molecular mechanisms un-
derlying these morphological and functional changes are only partly understood (Greg-
ory-Evans et al., 2013; Xiang, 2013). In mouse retina this terminal maturation process 
involves major morphological and functional changes largely occurring within a week 
after eye opening (Hoon et al., 2014; Okawa et al., 2014). The exact mechanisms that 
orchestrate retinal maturation are not known. Potential pathways may involve the de novo 
remodeling of epigenetic marks to facilitate silencing and/or activation of specific genes 
via DNA methylation and histone modifications.  
 
Figure 9. Synaptic wiring and terminal differentiation of neurons in mouse retina. 
Cartoon illustrating the sequence of postnatal maturation of the vertebrate retina, exemplified for 
the mouse. OS = outer segment, IS = inner segment, OLM = outer limiting membrane, ONL = 
outer nuclear layer, OPL= outer plexiform layer, INL = inner nuclear layer, IPL = inner plexiform 
layer, GCL = ganglion cell layer, ILM = inner limiting membrane.  
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1.8 The aims of this thesis 
 
The mechanisms controlling transcriptional changes during neuronal maturation are 
poorly understood. However rising evidence suggests that epigenetic events are crucial 
for proper transcriptional control and differentiation during this critical period. In this 
thesis particular interest was paid to unravel the role of 5hmC and TET3 during neuronal 
maturation in mouse retina. The rationale of the thesis is to address the following subjects: 
 
1.) Epigenetic role of 5-hydroxymethylcytosine 
5hmC is suggested to be an intermediate during DNA demethylation. However, several 
studies suggest that 5hmC can function as a stable epigenetic DNA base (Bachman et al., 
2014; Globisch et al., 2010; Szulwach et al., 2011). The aim of this study was to unravel 
the role of 5hmC during retinal maturation. Therefore, genomic distribution of 5hmC 
should be studied in immature retina (postnatal week 2) and adult retina (postnatal week 
3). Moreover, the effects of 5hmC accumulation on gene expression levels should be in-
vestigated. 
 
2.) Functional role of neuronal TET3  
The exact mechanisms on how 5hmC marks are established by TET enzymes are not 
known. It was suggested that the CXXC domain present in TET1 and TET3 is responsible 
for DNA binding. However, the predominant neuronal TET3 isoform is lacking a CXXC 
domain or any other DNA binding. Hypothesizing that neuronal TET3 interacts with tran-
scriptional regulators that mediate DNA binding and promote TET3 hydroxylase activity 
a screen for putative interaction partners should be performed.  
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2. Material and Methods 
 
2.1 Animals 
All mice used were on the C57BL/6 genetic background. All procedures concerning ani-
mals were performed with permission of the local authority (Regierung von Oberbayern). 
Day of birth was considered as postnatal day 1 (p1). All mice were given ad libitum access 
to food (Ssniff; regular feed: R/M-H, breeding feed: M-Z Extrudat) and water. Mice were 
maintained on a 12 h light/dark cycle. 
 
 
 
2.2 Chemicals, solutions and buffers  
All chemicals used were obtained by Bio-Rad, Fluka, Merck, Roth and Sigma-Aldrich if 
not mentioned otherwise. The quality was "pro analysi"or "for molecular biological use". 
For all solutions high pure and deionised water was used (Milli-Q Plus System, Milli-
pore). In experiments that required a high purity all solutions were autoclaved (Sterlisator, 
Münchener Medizin Mechanik). 
 
 
 
2.3  Cell culture and plasmid transfection 
Human embryonic kidney (HEK293) cells are a well-established over-expression system 
to investigate proteins and their function in vitro. For this purpose, HEK293T cells were 
transfected with plasmid DNA containing the protein of interest. All cell culture work 
was performed under a laminar flow (Hera Safe, Thermo Scientific) and aseptic condi-
tions. 
The following plasmids were used in this study: 
LV-CMV-TET3∆CXXC-eGFP (see also chapter 2.5) 
LV-CMV-eGFP (see also chapter 2.5) 
p6351-MSCV-CMV-CMV-Flag-HA-NSD3  (Plasmid #31357, Addgene) 
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pHR'-NRSF-CITE-GFP (Plasmid #21310, Addgene)  
HEK293T cells (DMSZ) were cultivated in DMEM + GlutaMAX medium (+ 4.5 g/l glu-
cose, - pyruvate + 10 % FBS) + 1 % penicillin/streptomycin (Biochrom) at 37 °C with 10 
% CO2 in an incubator (Heraeus Cells, Thermo Scientific). Transient transfections of 
HEK293T cells were performed using the calcium phosphate technique.  
The calcium phosphate based transfection was performed by adding following solutions 
to a 15 ml falcon tube (Sarstedt):  
DNA    20 μg 
2.5 M CaCl2   100 μl 
ddH2O   ad 1 ml 
While vortexing this mixture, 1 ml 2 x BBS solution was added in a drop-wise manner. 
Then, the mixture was incubated for max. 5 min. at room temperature. This mixture was 
added drop-wise to the 50-70 % confluent cells and the cells were incubated at 37 °C with 
5 % CO2 in an incubator (Hera Cell, Thermo Scientific). 24 h after transfection, the me-
dium was replaced and the cells were incubated at 37 °C for 24 h with 10 % CO2 in an 
incubator (Hera Cell, Thermo Scientific).  
 
2 x BBS Solution 
BES    10.65g 
NaCl    16.35g 
Na2HPO4· 2H2O  0.21g 
H2O    ad 950 ml  
adjust to pH 6.95 with NaOH and sterile filtrate using a 25mm syringe filter (VWR). 
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2.4  siRNA experiments 
For RNAi experiments, REST-specific siRNA duplexes or control siRNA duplexes (Or-
iGene, SR304036) and plasmid-expressing mouse TET3 were transfected using siTRAN 
(OriGene) in Opti-MEM I reduced serum medium (Invitrogen) according to the manu-
facturer’s instructions. Cells were incubated at 37 °C and 10% CO2 for 48 h in an incu-
bator (Hera Cell, Thermo Scientific) and subsequently harvested for genomic DNA iso-
lation using a cell scraper (VWR). Subsequently, the cells were centrifuged at 500 g for 
5 min and the supernatant was removed by pipetting. Samples were snap-frozen in liquid 
nitrogen and stored at -80 °C until use. Knockdown efficiency of gene expression was 
verified using RT-qPCR as described in chapter 2.16. Primers used for siRNA studies are 
listed in Table 5.  
 
 
 
2.5  Lentiviral plasmids 
The original lentivirus plasmids were provided by the lab of Inder Verma (The Salk In-
stitute for Biological Studies, Laboratory of Genetics, La Jolla, CA, USA). 
Mouse TET3 was PCR cloned from mouse retinal cDNA using the following primers: 
 5’- CTATCTAGAACCGCCATGGACTCAGGGCCAGTGTAC-3’ (forward)  
5’-TCACCGGTAAGATCCAGCGGCTGTAGGG-3’ (reverse)  
Tet3 was ligated into a lentiviral vector containing a cytomegalovirus (CMV) promoter 
(Mistrik et al., 2005), yielding LV-CMV-TET3∆CXXC-eGFP. LV-CMV-eGFP was used 
for control experiments.  
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2.6  Lentiviral production 
Lentiviral particles were produced in HEK293T cells (DSMZ). The following protocol 
refers to the production of two different LV constructs: 
A 14.5 cm plate (Greiner Bio-One) with 90-100 % confluent HEK293T cells was re-
suspended in 2 ml trypsin (0.05 % trypsin/EDTA) (Life Technologies) 16 ml DMEM + 
GlutaMAX medium (+ 4.5 g/l glucose, - pyruvate + 10 % FBS (Biochrom)) + 1 % peni-
cillin/streptomycin (Biochrom)  and was split to 2 x 14.5 cm plates (Greiner Bio-One) in 
an 1:9 dilution. Cells were incubated at 37 °C with 10 % CO2 in an incubator (Hera Cell, 
Thermo Scientific) for 96 h. Each plate was split in a 1:7 dilution to 6 x 14.5 cm in 20 ml 
DMEM + GlutaMAX medium (+ 4.5 g/l glucose, - pyruvate + 10 % FBS + 1 % penicil-
lin/streptomycin) and was incubated at 37 °C with 10 % CO2 for 24 h or until they were 
80 % confluent. The cells were transfected with the following transfection mixture: 
 
6 x 14.5 cm plates     
plasmid construct       108 µg     
pMDL         70 µg                     
RsvRe         32 µg  
pMD2.G        29 µg                            
CaCl2 (2.5 M) (drop-wise)      0.7 ml     
polybrene (8 mg/ml) (hexadimethrin bromid, Sigma)  7 µl    
dextran (10 mg/ml) (Fluka)     700 µl   
H2O (Sigma)        ad 12 ml    
  
In 50 ml falcon tubes (Sigma), vortex and add 6 ml 2x BBS (see also chapter 2.3) in a 
drop-wise manner, vortexed and incubated for 12 min at room temperature.  
2 ml of the transfection mixture was added to each plate. Subsequently cells were placed 
at 37 °C with 5 % CO2 for 24 h in an incubator (Hera Cell, Thermo Scientific). The 
medium was replaced with 16 ml fresh DMEM + GlutaMAX medium (+ 4.5 g/l glucose, 
- pyruvate + 10 % FBS) + 1 % penicillin/streptomycin (Biochrom) and placed at 37 °C 
with 10 % CO2 in an incubator (Hera Cells, Thermo Scientific). The virus containing 
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supernatant was harvested from the plates by filtration (0.45µm, Nalgene). 16 ml of fresh 
DMEM + GlutaMAX medium (+ 4.5 g/l glucose, - pyruvate + 10 % FBS) + 1 % penicil-
lin/streptomycin (Biochrom) was added to the cells and they were placed back at 37 °C 
for 10 % CO2. The filtrated medium was transferred in centrifugation tubes (Open-Top 
Thinwall Polypropylene, Konical Tube, Beckman & Coulter) and centrifuged for 2 h at 
19.400 rpm at 17 °C (SW 28 Rotor, Beckman & Coulter). The supernatant was removed 
using a vacuum pump (Vacusafe, Integra Biosciences). The pellet was resuspended in 
200 µl HBSS (Gibco) and was collected in a sterile 1.5 ml screw cap (Sarstedt). The 
samples were vortexed briefly and stored at 4 °C. On the following day the supernatant 
from the plates was again collected and filtered as mentioned above. 
The re-suspended pellets in HBSS were washed and concentrated by a second centrifu-
gation step in sucrose. Therefore, the samples were transferred to centrifugation tubes 
(Tube, Polypropylene, Thinwall, 5.0 ml, 13 x 51 mm, Beckman & Coulter) with 2 ml 20 
% sucrose (Applichem) in ddH20 (Sigma) and centrifuged for 2 h at 21.000 rpm 17 °C 
(SW55 Rotor, Beckman Coulter). The supernatant was carefully aspirated using a vac-
uum pump (Vacusafe, Integra Biosciences). The pellet was resuspended in 70 µl HBSS, 
collected in a new 1.5 ml screw cap, vortexed and incubated for 45 min in a thermocycler 
at room temperature and 1400 rpm (Thermomix, Eppendorf). After short centrifugation 
the supernatant was aliquoted in 1.5 ml screw caps containing 5 µl virus solution. Samples 
were stored at -80 °C until use. 
 
 
 
2.7  In vitro retinal explant cultures  
Retinal explant cultures were prepared following a protocol from Reidel et al (Reidel et 
al., 2006). Retina explant cultures were prepared under a laminar flow (Hera Guard, 
Thermo Scientific) and all media had been sterile filtered using a 25mm syringe filter 
(VWR).  
Retinas from wildtype animals (C57BL/6) were used to generate retinal explants. Ani-
mals were euthanized and the eyes enucleated in DMEM Nutrient Mixture F12-HAM 
medium (GIBCO® Dulbecco's Modified Eagle Medium, Life Technologies), containing 
10 % fetal bovine serum (FBS) (Biochrom) and 1 % antibiotics (penicillin/ streptomycin) 
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(Biochrom). Afterwards, the entire eyes were incubated in DMEM-F-12 (Sigma) serum 
free medium containing 0.12 % proteinase K (Sigma) for 15 min at 37 °C with 5 % CO2 
in an incubator (Hera Cell, Thermo Scientific). Next, proteinase K was inactivated using 
10 % fetal bovine serum (Biochrom) in DMEM Nutrient Mixture F12-HAM medium 
(Sigma) for 5 min at 37 °C with 5 % CO2 in an incubator (Hera Cell, Thermo Scientific). 
After rinsing the eyes three times in DMEM Nutrient Mixture F12-HAM medium (Life 
Technologies) without serum, the eyes were dissected aseptically using a stereoscopic 
microscope (Stemi 2000, Zeiss) in a 35 mm Petri dish (Cellstar, Greiner Bio-One GmbH). 
First the optic nerve was cut under slight tension using forceps and a micro-eye spring 
scissor (Mini Vanas, blade 3 mm, Frohnhäuser). Next, an incision was placed by gently 
inserting the scissor between the retinal pigment epithelium and the sclera. Afterwards 
the sclera was incised along the eyeball towards the cornea. Finally, the lens, vitreous, 
sclera, and choroids were carefully removed under preservation of retinal pigment epi-
thelium. Next, the retina was cut perpendicularly to its edges, resulting in a cloverleaf-
like shape. Subsequently, the retina was transferred to a Millicell culture dish filter insert 
(Millicell, Merck Millipore) with the retinal pigment epithelium layer facing the mem-
brane. The insert was put into a six-well culture plate (Cellstar, Greiner Bio-One) and 
incubated in DMEM-F12 nutrient medium containing 10 % fetal bovine serum (FBS) 
(Biochrom) and 1 % antibiotics (penicillin/streptomycin) (Biochrom) at 37 °C with 5 % 
CO2 in an incubator (Hera Cell, Thermo Scientific). Every second day, the full volume of 
the nutrient medium, 1.2 ml per well, was replaced with fresh DMEM Nutrient Mixture 
F12-HAM medium (Life Technologies), containing 10 % fetal bovine serum (FBS) (Bi-
ochrom) and 1 % antibiotics (penicillin/streptomycin) (Biochrom). 
 
 
 
2.8  Metabolic feeding with [methyl-13CD3]-methionine 
De novo methylation tracing experiment was performed using [methyl-13CD3]-methio-
nine (heavy methionine) that was incorporated to the DNA as [13C, D3] 5mC by DNA 
methyltransferases (DNMT) (Figure 10A) (Bachman et al., 2014; Pfaffeneder et al., 
2014). Further oxidation of [13C, D3] 5mC by TET enzymes led to the formation of [hy-
droxymethyl-13C, D2] 5hmC (de novo 5hmC), [formyl-13C, D] 5fC (de novo 5fC) and [carboxy-
13C] 5caC (de novo 5caC) (Figure 10B) (Pfaffeneder et al., 2014).  
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Figure 10. De novo methylation tracing experiments. 
(A) De novo metabolic tracing experiments were performed in methionine free medium supple-
mented with [13C,D3]-labeled L-methionine that is incorporated as [13C, D3] 5mC.(de novo 5mC). 
(B) de novo 5mC can be further oxidized by TET enzymes to [hydroxymethyl-13C, D2] 5hmC (de 
novo 5hmC), [formyl-13C, D] 5fC (de novo 5fC) and [carboxy-13C] 5caC (de novo 5caC).   
 
To investigate de novo methylation and potential de novo 5mC oxidation in mouse retina, 
feeding experiments were performed in 11-day-old (p11) retinal explant cultures (Figure 
11). Retinal explant cultures were prepared as described in chapter 2.3 except that DMEM 
Nutrient Mixture F12-HAM medium (Life Technologies) was replaced with custom L-
methionine-free DMEM-KO (Invitrogen).  
Retinal explant cultures were maintained in custom L-methionine-free DMEM-KO (Invi-
trogen) containing 10% FBS (Biochrom) and supplemented with 2 mM of [methyl-
13CD3]-methionine (Sigma) for 9 days (after three days of incubation media was renewed) 
at 37 °C and 5 % CO2 in an incubator (Hera Cell, Thermo Scientific) (Figure 11). Four 
retinal cultures were collected each three days after feeding and pooled for subsequent 
HPLC-MS/MS quantification that was conducted by Mirko Wagner (Carell group, LMU 
Munich). 
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Figure 11. Schematic overview of metabolic tracing experiments. 
De novo metabolic tracing experiments were performed using [13C, D3]-labeled L-methionine in 
p11 retinal explants. 5mC and 5hmC levels were quantified after 3, 6 and 9 days of culturing 
using HPLC-MS/MS.   
 
 
 
2.9 LV transduction of retinal explant cultures  
Retinal explant cultures from 11-day-old mice were used for transduction experiments 
using LV-CMV-TET3∆CXXC-eGFP (neuronal TET3) or LV-CMVeGFP (control). 
Twelve retinae were used for each experiment. The LV particles were added to the scleral 
and vitreal part of retinal explants directly after preparation of the explant cultures. Every 
second day, the full volume of DMEM-F12 (Life Technologies), 1.2 ml per well (Cellstar, 
Greiner Bio-One), was replaced with fresh DMEM-F12 medium. Retinal explants were 
harvested after 12 days in vitro culturing. The retinal explants were snap frozen in liquid 
nitrogen and stored at - 80 °C for nuclear protein extraction. 
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2.10  Genomic DNA isolation 
The Blood and Cell Culture DNA Midi Kit (Qiagen) was used to extract genomic DNA 
(gDNA), following the manufacturer´s instruction for cell culture samples or tissue sam-
ples, respectively. Additionally, all buffers until loading of the sample on Genomic-tip 
100/G were supplemented with the antioxidants 2, 6-di-tert-butyl-4-methyl-hydroxytol-
uene (BHT, 200 μM) (Sigma), deferoxamine mesylate salt (desferal, 200 μM) (Sigma) 
and deaminase inhibitor tetrahydrouridine (THU, 200 μM) (Sigma). Moreover, the elu-
tion buffer QF was supplemented with 200 μM BHT. The following protocol was opti-
mized for 25 mg tissue weight.  
Tissue samples were homogenized with 2 ml Q2 buffer and a stainless steel bead in a 
TissueLyser (Qiagen) at 30 Hertz (Hz) for 2 min. Buffer G2 lyses the nuclei and denatures 
proteins such as nucleases, histones, and viral particles. The excess QIAGEN Protease 
digests the denatured proteins into smaller fragments. Next, 20 µl proteinase K (Qiagen) 
were added and the solution was incubated for 3 h at 56 °C. Subsequently, DNase-free 
RNase A (4 ml, 100 mg/ml, Qiagen) was added and incubated for 5 min under shaking 
(600 rpm, Thermomixer, Eppendorf) at room temperature. Buffer G2 and QIAGEN Pro-
tease, in combination, were used to strip the genomic DNA of all bound proteins, facili-
tating efficient removal during purification. The sample was vortexed and transferred 
onto a QIAGEN Genomic-tip. The samples were allowed to enter the resin by gravity 
flow. The samples were washed 3 times using 1 ml Buffer QC and eluted using 1 ml 
Buffer QF. 
After elution, all steps were performed at 4 °C or on ice. The genomic DNA samples were 
precipitated with NaOAc (0.3 M final) and 0.7 volumes isopropanol. The samples were 
mixed and centrifuged immediately at 5.000 x g for 15 min at 4 °C using a micro centri-
fuge (Fresco 17, Thermo Scientific). The supernatant was carefully removed by pipetting. 
Samples were resuspended in ddH2O containing 200 μM BHT. HPLC-MS/MS quantifi-
cation were performed by Mirko Wagner (Carell group, LMU Munich) and Jessica Steinbacher 
(Carell group, LMU Munich). 
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2.11  DNA immunoprecipitation 
DNA fragmentation was performed as described in Mohn et al (Mohn et al., 2009). First, 
15 µg of isolated retinal gDNA ad 300 µl TE-Buffer was fragmented to an average size 
of 500 bp by sonication (Branson) applying 5 consecutive fragmentation steps each with 
an amplitude of 20 % for 10 s and 1 min pause after each pulse. hMeDIP was performed 
according to manufacturer’s manual (Active Motif) (Figure 12). 3 µg of DNA and 4 µl of 
rabbit 5-hmC pAB (Active Motif, #39770) were incubated at 4 °C with end-to-end rota-
tion overnight. To perform DNA capture the antibody-bound DNA was incubated with 
25 µl Protein G magnetic beads (Active Motif) for 2 h at 4 °C with end-to-end rotation. 
After removal of the supernatant the beads were washed three times with wash buffers 
that contain nonionic surfactants and salts. In the first washing step 200 µl ice-cold wash-
ing buffer (buffer C, Active Motif) was used and for the second and third washing step 
200 µl ice-cold washing buffer (buffer D, Active Motif) were used. The beads were re-
suspended using 50 μl acidic elution buffer (buffer AM2, Active Motif). After 15 min 
incubation at room temperature with end-to-end rotation 50 μl TRIS-HCl based buffer 
was added to increase the pH (Neutralization Buffer, Active Motif).  
The enriched 5hmC-containing DNA was purified using the Chromatin IP DNA Purifi-
cation Kit (Active Motif). First, 500 µl binding buffer (Active Motif) was added to 100 
µl of each sample DNA and 5 µl 3 M sodium acetate (Active Motif) was added and mixed 
by pipetting. The color of the DNA sample / DNA Purification Binding Buffer mixture 
should be bright yellow, not light orange or violet. If the color was light orange or violet 
the pH was above 7.5. Thus, if necessary more 3 M sodium acetate was added (5 µl steps) 
and mixed until the pH was below 7.5. The correct pH was important for successful bind-
ing and purification of the DNA due to the fact that the elution buffer had a basic pH. A 
DNA purification column (Active Motif) was placed in the collection tube (Active Motif) 
and the sample was added on the column. Subsequently, the samples were centrifuged at 
14.000 rpm for 1 min in a micro centrifuge (Fresco 17, Thermo Scientific). The flow 
through was discarded and 750 μl of wash buffer (Active Motif) was added. Next, the 
samples were centrifuged again at 14.000 rpm for 1 min. After removal of the flow 
through the samples were centrifuged at 14.000 rpm for 2 minutes in a microcentrifuge 
to remove any residual wash buffer from the column. The columns were transferred to 
clean 1.5 ml tubes (Eppendorf tube, Eppendorf) and 50 μl of DNA Purification Elution 
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Buffer (Active Motif) was added to the center of the column matrix and incubated for 1 
min. Next, the sample was centrifuged at 14.000 rpm for 1 min and the DNA concentra-
tion of the eluted DNA was measured using Nanodrop 2000c (Thermo Scientific). The 
samples were stored at -20 °C until use. Paired-end libraries were prepared using the 
paired-end TruSeq DNA sample prep kit (Illumina inc.) and performed by HiSeq 2000 
instruments (Illumina inc.).  
 
 
Figure 12. Schematic overview of the hMeDIP experiment. 
(A) First DNA is isolated from mouse retinal tissue as described in chapter 2.7. (B) After that the 
DNA is sheared using a sonicator. (C) The DNA fragments are incubated with the primary anti-
body (rabbit anti-5hmC antibody). Next Protein G magnetic beads are added to the solution. The 
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magnetic beads – DNA complex is captured using a magnetic rack and washing steps are per-
formed. After acidic elution and subsequent neutralization the DNA is purified and stored at -20 
°C for further use. Adapted from http://www.diagenode.com/media/catalog/file/hMeDIP-_kit-
manual. 
 
 
2.12  hMeDIP qPCR validation 
To validate the hMeDIP sequencing results, specific genomic regions were chosen that 
showed higher levels of 5hmC at postnatal week 3 compared to week 2 (gained 5hmC), 
lower levels of 5hmC at postnatal week 3 compared to week 2 (lost 5hmC) and stable 
regions that did not display alterations of 5hmC levels during retinal. First hMeDIP was 
performed and the 5hmC enriched DNA was purified as described in chapter 2.11.  qPCR 
validation of selected 5hmC regions was performed using 200 ng of eluted DNA in du-
plicate 10 μl qPCR reactions (n=3). 
 
10 μl PCR reactions  
Fast SYBR Green master mix 
5 μl 
Forward primer* (5 pmol/μl) 0.5 μl 
Reverse primer* (5 pmol/μl) 0.5 μl 
Sterile water 1 μl 
DNA sample (eluted DNA) 3 μl 
Total volume 10 μl 
Fold enrichment was calculated as 2−dCT, where dCT = CT (5hmC week 2) − CT (5hmC 
week 3). Primers used in hMeDIP-qPCR are listed in Table 4. 
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2.13 Origin of mouse embryonic stem cells 
Mouse embryonic stem cells (mESC) for gene expression studies were kindly provided 
by Markus Moser (Max-Planck-Institute for Biochemistry). 
 
 
 
2.14  RNA extraction  
Total RNA extraction was performed using the RNeasy-Mini Kit (Qiagen) according to 
the manufacturer’s protocol. Briefly, 350 µl RLT Buffer was added to each retina (ap-
proximately 15 mg tissue). The tissue was disrupted and homogenized using a 27G needle 
(Sterican) and a 1 ml syringe (Terumo). The lysates were pipetted directly onto a QI-
Ashredder spin column (Qiagen). The samples were centrifuged for 2 min at full 10.000 
rpm. The supernatant was carefully transferred to a new microcentrifuge tube. 350 µl of 
70 % ethanol was added to the lysate, and mixed well by pipetting. The sample, including 
any precipitate, was transferred to an RNeasy MinElute spin column (Qiagen). The sam-
ple was centrifuged for 15 s at 10.000 rpm in a microcentrifuge (Fresco 17 microcentri-
fuge, Thermo Scientific). Next, 350 µl Buffer RW1 was added to the RNeasy MinElute 
spin column. The sample was again centrifuged for 1 min at 10.000 rpm and 10 µl DNase 
I stock solution was added to 70 µl Buffer RDD. The DNase I incubation mix (80 µl) was 
added to the RNeasy MinElute spin column membrane, and placed on the benchtop at 
room temperature for 15 min. Next 350 µl Buffer RW1 was added to the RNeasy MinE-
lute spin column and centrifuged for 15 s at 10.000 rpm. 500 µl Buffer RPE was added 
to the spin column and centrifuged for 15 s at 10.000 rpm. Next, 500 µl of 80 % ethanol 
was added. The RNA was eluted by adding 12 µl RNAse-free water directly to the center 
of the spin column membrane and centrifuging for 1 min at full speed.  
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2.15  cDNA synthesis 
Reverse Transcription (RT) was performed using the RevertAid First Strand cDNA Syn-
thesis Kit (Thermo Scientific) according to the manufacturer’s manual. In brief the fol-
lowing reagents were added into a sterile, nuclease-free tube on ice in the indicated order: 
cDNA synthesis mixture (total volume: 20 µl) 
Template RNA/total RNA:      200 ng  
primer: oligo (dT) 18 primer      1 µl  
random hexamer primer      1 µl 
water, nuclease-free / add volume to    12 µl 
5 x Reaction buffer       4 µl 
RiboLock RNase Inhibitor (20 u/µl)    1 µl 
10 mM dNTP Mix       2 µl 
RevertAid M-MuLV Reverse Transcriptase (200 u/µl)  1 µl 
 
The sample was mixed gently, centrifuged and incubated for 5 min at 25 °C followed by 
60 min at 42 °C. The reaction was terminated by heating at 70 °C for 5 min. The cDNA 
was used directly for qPCR or stored at - 80 °C for long-term storage. 
 
 
 
2.16 quantitative PCR (qPCR) 
qPCR was performed on a LightCycler 480 System (Roche) using KAPA SYBR FAST 
(Peqlab). Standard curves for each amplified transcript were generated to obtain the PCR 
efficiency. CT values were determined by the LightCycler® Software 480 (Roche) using 
the following protocol:  
program name    cycles               analysis mode 
pre-Incubation    1               none   
amplification     45              quantification  
melting curve     1               melting curves  
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target acquisition mode  hold   ramp rate  acquisitions 
(°C)     (hh:mm:ss)  (°C/s)  (per °C)  
pre-incubation  
95    none    00:05:00   4.8   –  
amplification  
95    none    00:00:10  4.8   – 
 primer dependent  none    00:00:10  2.5   –  
72    single    00:00:15  4.8   – 
melting curve  
95    none    00:00:05    –  
65    none    00:01:00    –  
98    continuous   –   –   5 – 10  
Table 2. Parameters for RT-qPCR. 
Expression levels of each sample were detected in duplicate reactions. Three different biological 
samples were analyzed in duplicates and normalized to the expression of the housekeeping gene 
aminolevulinic acid synthase (ALAS). Relative quantification was determined by the method de-
scribed by Pfaffl (2002). The data were presented as mean ± SEM.  
 
 
 
2.17 Retina preparation  
The mice were euthanized and to track the orientation of the retina until cryosectioning a 
temporal mark was placed on the eyeball using a glowing needle. The eyes were removed 
and pierced at the ora serrata using a cannula (21G, Sterican, B. Braun) and prefixed using 
4% PFA (paraformaldehyde) for 5 min on ice. Next, the cornea was opened using a micro-
eye spring scissor (Mini Vanas, blade 3 mm, Frohnhäuser) under a dissecting/stereo-
scopic microscope (Stemi 2000, Zeiss). The burnt-in mark placed on the ora serrata was 
restored by placing a small incision into the retina. Subsequently, cornea, lens and vitre-
ous body were dislodged. Subsequently, the eyecup was fixed for 45 min in 4 % PFA on 
ice. Next, the eyecup was washed thrice in 0.1 M PB and dehydrated overnight in 30 % 
sucrose for cryopreservation. Finally, the eyecup was embedded in tissue freezing me-
dium (Electron Microscopy Sciences), frozen on dry ice and stored at - 80 °C until use. 
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0,1 M PB  
Na2HPO4 x 2 H2O      28.48 g    
NaH2PO4 x H2O      5.52 g     
H2O        ad 2 l     
pH 7.4, stored at 4 °C. 
 
4% PFA (in PB)  
Paraformaldehyd (Merck)     6 g  
0.1 M PB       ad 150 ml  
dissolved at 60 °C and sterile filtered using a 25mm syringe filter (VWR). Aliquots were 
stored at – 20 °C.  
 
30% sucrose solution (in PB) 
sucrose       30 g  
0.1 M PB       70 ml  
0.1 M PB       ad 100 ml  
sterile filtered using a 25mm syringe filter (VWR) and stored at - 20 °C.  
 
 
 
2.18 Retinal cryosections 
 
Retinal cryosections were prepared using the embedded eyecups in tissue freezing me-
dium. Using a kryostat (Leica CM3050 S, Leica Biosystems) the embedded tissue was 
sliced to 10 µm cryosections and mounted on glass object slides (SuperFrost Plus, Men-
zel). The cryosections were dried at room temperature and stored at - 20 °C.  
 
 
 
2.19 Immunohistochemistry  
Coronal retinal cryosections (12 µm) from 2 and 3 week old C57-BL6/N mice were re-
hydrated in sterile 0.1 M phosphate buffered (PB) and fixed for 10min with 4 % para-
formaldehyde (PFA) in 0.1 M PB, pH 7.4. Cryosections were treated with 2N HCl in  
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0.1 M PB for 20 min and incubated for 1.50 h at room temperature (RT) or overnight at 
4 °C with primary antibodies in 5 % chemiblocker (Millipore) and 0.3 % Triton X-100 in 
sterile 0.1 M PB. The cryosections were subsequently washed 3 times with 0.1 M PB.  
The following primary antibodies were used (catalogue number and working dilutions in 
brackets):  
polyclonal rabbit anti-5hmC (Active Motif, #39769, 1:1000) 
monoclonal mouse anti-5mC (Diagenode, #BI-MECY-0100; 1:1000).  
For 5hmC depletion experiment the anti-hmC staining signal was competed out by 2mM 
hmC-DNA oligonucleotides.  
The following secondary antibodies were used (catalogue number and working dilutions 
in brackets):  
Alexa488 anti-rabbit (1:800, Cell Signaling Technologies)  
Cy3 anti-mouse (1:400, Jackson ImmunoResearch)  
Cell nuclei were counterstained with Hoechst 33342 (5 µg/mL, Invitrogen) and sections 
were mounted with aqueous mounting medium (PermaFluor, Beckman-Coulter). Tissues 
were analyzed using a Zeiss Axioscope epifluorescence microscope equipped with a 
HBO 100 mercury arc lamp, appropriate filters equipped with an MRc ccd camera (Zeiss). 
Laser scanning confocal micrographs were collected using a Leica SP8 microscope 
(Leica).  
 
 
 
2.20 Proximity ligation assay 
Proximity ligation assay (PLA) was performed using Duolink In Situ Orange Starter Kit 
Mouse/Rabbit (Sigma-Aldrich) according to the manufacturer's manual (Figure 13). 
HEK293T cells or retinal slices were fixed and permeabilized as described in the immu-
nofluorescence studies. Subsequently, the samples were incubated with the supplied 
blocking solution for 10 min (retinal slices) or 30 min (cells) at room temperature. After 
washing, the cells were incubated with mouse and rabbit primary antibodies over night at 
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4 °C. Next, the samples were washed three times in 0.1 M phosphate buffer and incubated 
with the PLUS and MINUS PLA probes in a humid chamber for one hour at 37 °C. Sub-
sequently, samples were washed two times in Buffer A (supplied). Ligation was per-
formed at 37 °C for 30 min followed by washing in Buffer A. Amplification was per-
formed for 100 min at 37 °C. After washing with Buffer B the samples were stained with 
Hoechst, washed again and mounted using PermaFluor Aqueous Mounting Medium 
(Thermo Scientific). Fluorescence signal intensity was normalized to background fluo-
rescence levels of control PLA stainings incubated without primary antibody. The aver-
age of signals/nuclei in at least 20 cells from at least two independent experiments was 
reported in the graphics.  
We used the following primary antibodies (working dilutions in brackets):  
mouse monoclonal anti-5hmC (Active Motif, #40000, 1:1,000) 
mouse monoclonal anti-5mC (Diagenode, #BI-MECY-0100; 1:1000) 
rabbit polyclonal anti-REST (#095, kindly provided by Gail Mandel, Oregon Health & 
Science University, 1:500)  
rabbit polyclonal anti-H3K36me3 (Active Motif, # 61102, 1:1000). 
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Figure 13. Schematic workflow of PLA experiment.  
(A) The cryosections are incubated with two primary antibodies from different species (e.g. anti-
5hmC and anti-H3K36me3. (B) Plus and minus PLA probes (secondary antibodies) are added.  
The attached DNA strands can interact by subsequent hybridization of two connector DNA oli-
gonucleotides, if the secondary antibodies are in close proximity (<40 nm) (C) The two oligonu-
cleotides are ligated enzymatically and amplified by a polymerase in a rolling circle amplification 
reaction. (D) The amplified DNA circles are hybridized with detector probes.  
 
 
 
2.21 Nuclear extract preparation  
Cell lysis of retina tissue samples was performed according to the Sigma Aldrich protocol 
for detergent free nuclear protein extraction (http://www.sigmaaldrich.com/technical -
documents/protocols/biology/nuclear-protein-extraction.html). In brief, for each experi-
ment 50 - 150 mg retinal tissue was lysed. The following procedure was optimized for 
extraction of nuclear proteins from 100 mg of tissue. A fresh solution of 0.1 M DTT with 
ultrapure sterile water, a hypotonic lysis buffer and an extraction buffer was prepared: 
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lysis buffer (hypotonic)  
HEPES, pH 7.9 10 mM 
MgCl2   1.5 mM 
KCl   10 mM 
14 µl of 0.1 M DTT solution and 14 µl of the Protease Inhibitor Cocktail (PIC; Active 
Motif) were added to 1.4 ml of lysis buffer.  
extraction buffer 
HEPES, pH 7.9  20 mM 
MgCl2   1.5 mM 
NaCl   0.42 M 
EDTA   0.2 mM 
glycerol  25 % (v/v) 
1.5 µL of 0.1 M DTT solution and 1.5 µl of the protease inhibitor cocktail were added 
to 147 µl of the extraction buffer. 
The tissue was rinsed twice with 0.1 M PB buffer and the supernatant was discarded. The 
tissue was resuspended in 1 ml lysis buffer and homogenized using mortar and pestle until 
more than 90 % of the cells were broken and nuclei were visualized under the microscope. 
The disrupted cells were centrifuged for 20 min at 10.000 x g in a microcentrifuge (Fresco 
17 microcentrifuge, Therme Scientific) and the supernatant was transferred to a fresh 
tube. This fraction was the cytoplasmic fraction. The crude nuclei pellet was resuspended 
in 140 µl extraction buffer. The samples were shaken gently for 30 min and subsequently 
centrifuged for 5 min at 21.000 x g. Samples were stored at – 80 °C for long-term storage. 
To assess the protein concentration of the lysates, a Bradford protein assay (Thermo Sci-
entific) was performed according to the manufacturer’s instructions. Nuclear extracts for 
label-free quantification (LFQ) were additionally treated with 25 U benzonase for 30 min 
on ice. Protein samples for mass spectrometric analysis were reduced by adding 100 mM 
tris-2-carboxyethyl)phosphine (TCEP) (Sigma) and by incubating on a shaker (Thermo-
mixer Compact, Eppendorf) at 650 rpm for 1 h at 60 °C and subsequently alkylated with 
200 mM iodoactetamide (Sigma) in the dark for 30 min at 25 °C. Protein samples were 
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digested with 0.5 µg trypsin (Promega) for 16 h at 37 °C. The reaction was stopped using 
1 mM phenylmethylsulphonylfluoride (Sigma). StageTips (Thermo Scientific) were used 
to purify LFQ samples as described in (Kulak et al., 2014).  
 
 
 
2.22 Co-immunoprecipitation (Co-IP) 
Immunoprecipitations were performed using Protein G Dynabeads (Invitrogen) accord-
ing to manufacturer’s manual. Briefly, nuclear protein extracts were prepared without the 
use of detergents as described in chapter 2.21. 100 µl beads were added in a 1.5 ml Ep-
pendorf tube together with a primary antibody.  
The following primary antibodies were used (source, catalogue number and working di-
lutions in brackets):  
rabbit polyclonal anti-TET3 (Abiocode, #AC-R1092-1 1:25) 
polyclonal rabbit anti-REST (#095, kindly provided by Gail Mandel, Oregon Health & 
Science University, 1:25) 
rabbit polyclonal anti-GFP (Clonetech, #632377; 1:20)  
Next, the volume was adjusted to 500 µl using 0.1 M PBS and incubated for 30 min at 4 
°C under rotation. 25 µl of BS3 solution (Life Technologies) (5.7 mg BS3 in 100 µl 
ddH20) was added to each sample and incubated for 30 min at RT under constant rotation. 
The excess crosslinker was inactivated by adding 25 µl 1M Tris buffer pH 7.5 and incu-
bating for 15 min at RT under rotation. After short centrifugation the tubes were placed 
on a magnet rack for precipitation and the supernatant was discarded. The beads were 
washed twice with 300 µl 1 M PBS solution. Subsequently, 500 µg protein lysate was 
added to the beads and incubated for 60 min at 4 °C under rotation. The supernatant was 
discarded and the beads were washed 5 times with 300 µl 1M PBS solution. Proteins were 
eluted twice from beads using 30 µl citrate solution (0.1 M citrate, pH 2-3 (pH 2.2 used). 
Protein concentration of the samples before and after immune precipitation was measured 
using a Bradford protein assay. From each sample 50 µg protein were digested using 
trypsin and labeled with TMT 2-plex reagents to quantify changes in the protein compo-
sition of the samples. After labeling, the volume of the peptide samples was reduced to 5 
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µl in a vacuum centrifuge and filled up with 50 µl H2O containing 0.1 % formic acid. 
Samples were subsequently purified using reverse phase sulfonate (SDB-RPS) stage tips 
and processed according to (Kulak et al., 2014). 
 
 
 
2.23 Protein isolation for GFP-immunoprecipitation 
Retinal explant cultures from 11-day-old mice were transduced with LV-CMV-
TET3∆CXXC-eGFP or LV-CMV-eGFP and harvested after 12 days in vitro. Immuno-
precipitation of nuclear extracts were performed using a GFP-Trap (Chromotek) under 
detergent free conditions. GFP Trap beads were equilibrated in dilution buffer. 30 µl of 
the bead slurry was resuspended in 500 µl ice cold dilution buffer. Nuclear protein lysates 
(see chapter 2.13) were added to the equilibrated GFP-Trap and incubated with gentle 
end-over-end mixing for 2 h at 4 °C. Samples were centrifuged at 2.000 x g for 2 min at 
4 °C in a microcentrifuge (Fresco 17, Thermo Scientific) and the supernatant was stored 
as negative control. The pellet was washed twice with 500 µl ice cold wash buffer and 
proteins were eluted by adding 50 µl 0.1 M glycine pH 2.5 (incubation time: 2 min) fol-
lowed by neutralization with 5 µl 1 M Tris-base. 
dilution buffer                                      wash buffer 
10 mM Tris/Cl pH 7.5    10 mM Tris/Cl pH 7.5 
150 mM NaCl      150 mM NaCl  
0.5 mM EDTA     0.5 mM EDTA 
 
 
 
2.24 TMT-labeling for protein quantification 
For the TMT-based quantification, peptide labeling with the TMT 2-plex reagents 
(Thermo Scientific) was performed after tryptic digestion according to the manufacturer’s 
instructions. TMT 2-plex reagents (126 and 127) were used to label the samples.  
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When the sample was labeled with TMT 126 the control sample was labeled with the 
TMT 127 reagent and vice versa. Subsequent to the labeling, both sample and control, 
were combined. This way each experiment was performed twice as a so-called label swap 
experiment. Organic solvent was removed by vacuum centrifugation and the sample was 
finally reconstituted in 1 % formic acid for mass spectrometric analysis. TMT labelling 
and LC-MS analysis was conducted by Dr. David Eisen (Carell group, LMU Munich). 
 
 
 
2.25 Acid extraction of histones 
To examine histone modifications of histone 3 (H3), we followed a protocol from 
Shechter at al. (Shechter et al., 2007). 100 mg of cells (retinal cells or HEK293T cells) 
were lysed in 1 ml hypotonic buffer.  
hypotonic buffer 
10 mM Tris–HCl pH 8.0 
1 mM KCl 
1.5 mM MgCl2 / 1 mM DTT 
Subsequently, samples were incubated for 30 min under rotation at 4 °C to promote hy-
potonic swelling of cells and lysis by mechanical shearing during rotation. The intact 
nuclei were centrifuged at 10.000 x g (Fresco 17, Thermo Scientific) for 10 min at 4 °C. 
The supernatant was discarded and the nuclei were resuspended in 400 µl 0.4 N H2SO4 
and incubated under rotation for 30 min. It is important that nuclei were fully resuspended 
with no clumps left in solution. Thus, the solution was vortexed until clumps were dis-
solved. The nuclear debris was removed by centrifugation at 16.000 x g for 10 min at 4 
°C using a table top centrifuge (Fresco 17, Thermo Scientific). The supernatant contain-
ing histones was transferred to a new 1.5 ml Eppendorf tube (Eppendorf). Next, 132 µl 
trichloroacetic acid (TCA) was added drop-wise to the sample and inverted several times. 
The samples were incubated for 30 min on ice to precipitate histones. Histones were pel-
leted by 16.000 x g for 10 min at 4 °C and washed with 400 µl acetone without disturbing 
the pellet to remove remaining acid from the solution. Acetone was used to remove acid 
from the solution without dissolving the protein pellet.  The sample was spun for 5 min 
at 16.000 x g at 4 °C in a table top centrifuge. Next, 400 µl acetone were added again and 
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the samples were centrifuged for 5 min at 16.000 x g at 4 °C. The supernatant is carefully 
removed by pipetting and the histone pellet was air-dried for 20 min at room temperature. 
The pellets were solubilized using 100 µl of ddH20 and 6 µl of Laemmli DTT (6x 
Laemmli DTT) was added. Subsequently, the samples were heat denatured at 95°C for 5 
min and stored at - 20 °C until use.  
6x Laemmli DTT 
4x Tris-HCl/SDS pH 6.8  7 ml 
Glycerol    3 ml 
SDS     1 g 
bromphenol blue   1.2 mg 
DTT     930 mg 
ddH2O     ad 10 ml 
 
 
 
2.26 Quantification of histone modifications 
For the quantification of the total levels of H3K36me3 in retinal cells the TMT 2-plex rea-
gents (Thermo Scientific) was used. For the quantification of H3K36me3 in HEK293T cells 
the TMT 6-plex reagents (126, 127, 128 and 129, Thermo Scientific) were used to label the 
samples. The samples obtained from chapter 2.24 were loaded on a 10 % SDS PAGE and 
separated at 100V in a electrophorese chamber (Protean 3, Biorad). The gel was stained 
in a coommassie (Applichem) solution for 1 h and destained overnight in coomassie des-
taining solution.  
 
stacking gel buffer    separating gel buffer 
Tris-HCl   0.5 M  Tris-HCl   1.5 M 
SDS    0.4 %  SDS    0.4 % 
pH     6.8   pH     8.8 
 
 
stacking gel     10 % separating gel 
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30 % acrylamide/    30 % acrylamide/ 
0.8 % bisacrylamide  0.65 ml 0.8 % bisacrylamide  5.0 ml 
stacking gel buffer  1.25 ml separating gel buffer  3.75 ml 
ddH2O    3.05 ml ddH2O    6.25 ml 
20 % ammonium persulfate 25 μl  20 % ammonium persulfate 30 μl 
tetramethylethylenediamine 5 μl  tetramethylethylenediamine 10 μl 
 
coomassie staining solution    coomassie destaining solution 
Coomassie blue R250  1 g  methanol   10 % 
methanol    45 %  acetic acid 100 %  10 % 
acetic acid 100 %   10 %  ddH2O    ad 1000 ml 
ddH2O    ad 1000 ml    
Next, the visible protein band of histone H3 was cut out. The protein was in-gel alkylated 
and tryptically digested (Shevchenko et al., 2006). Trypsin activity was stopped using 1 
mM PMSF (Sigma) and the peptides were TMT-labeled according to manufacturer’s pro-
tocol (Thermo Scientific). Post-labeled samples of each experiment were pooled together 
and analyzed via LC-MS/MS. The relative reporter ion intensities of the trimethylated 
H3K36 peptide (SAPATGGVK(me3)KPHR) were normalized to the relative quantities 
of the whole protein. Finally, the fold change of the trimethylated peptides was calculated 
in relation to each control sample. 
 
 
 
2.27 Bioinformatics 
Sequence reads (read length = 100) of 5hmC containing DNA fragments were mapped 
onto the reference mouse genome (NCBI Build UCSC mm9) using the Bowtie (v0.12.7) 
algorithm. Peak-calling was performed using MACS Version 1.4 (http://liulab.dfci.har-
vard.edu/MACS/). Unique and monoclonal reads were used for further analysis. Mini-
mum criteria for peaks was 4 reads and peaks had to overlap within the replicates. Over-
lapping peaks in all samples were defined as conserved peaks. If peaks only overlapped 
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at postnatal week 2, they were considered as lost peaks. If peaks only overlapped at post-
natal week 3, they were considered as gained peaks. Refseq genes were downloaded from 
the UCSC mm9 annotation database (UCSC Genome Browser, Santa Cruz, CA). Gene 
ontology analyses on differentially hydroxymethylated regions were performed using In-
genuity (IPA, Ingenuity Systems, www.ingenuity.com).  
The MaxQuant software (version 1.5.0.25) was used for LFQ. Quantification was per-
formed with four biological replicates of the retinal tissue samples and biological tripli-
cates of the transfected HEK293T cells. In the overexpressing HEK293T experiments 
HEK293T cells transfected with GFP served as control. The Andromeda search engine 
was used in combination with uniprot databases (mus musculus for the retinal full prote-
ome analysis and homo sapiens for the overexpression analysis respectively). A maxi-
mum of two missed cleavage sites was allowed. The main search peptide tolerance was 
set to 10 ppm. Carbamidomethyl (C) was set as static modification. Variable modifica-
tions were Acetyl (Protein N-term) and Oxidation (M). Data of the cytoplasm and nucleus 
samples from the transfected HEK293T cells were analyzed as two different fractions of 
one experiment. The fast LFQ algorithm was applied with default settings. LFQ data was 
analyzed with the Perseus software (version 1.5.0.9). The LFQ intensities were log trans-
formed and only proteins identified in at least three of the retinal tissue samples or in at 
least two of the transfected HEK293T lysates were retained. LFQ Proteomics and 
MaxQuant Analysis was performed by Andrea Künzel (Carell group, LMU Munich). 
 
 
 
2.28 Statistics 
All values are given as mean ± standard error of the mean (S.E.M) or mean ± standard 
deviation (SD) and n is the number of experiments. An unpaired Student's t-test was per-
formed for the comparison between two groups. Values of p < 0.05 were considered as 
significant. Fisher’s exact-test was applied to analyze significance of contingency tables.  
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3. Results 
 
3.1 Transcriptional changes during retinal maturation 
First, transcriptional changes during retinal maturation were investigated. Retinal protein 
levels of 2-week-old mouse retina (eye opening) and 3-week-old mouse retina (mature 
state) were isolated and quantified using label-free quantification (LFQ) (Figure 14A). 
The volcano plot shows all the proteins identified with this approach. Proteins that 
showed significantly lower expression at week 3 compared to week 2 are marked in black, 
whereas upregulated proteins are marked in blue. Proteins with no significant change in 
expression are marked in grey (Figure 14A). Interestingly, gene ontology (GO) analysis 
using the Database for Annotation, Visualization and Integrated Discovery (DAVID) 
(http://david.abcc.ncifcrf.gov/) reveals that a significant amount of upregulated proteins 
were involved in synaptic functions, detection of light stimulus and phototransduction 
(Figure 14B), suggesting that major transcriptional changes occur during retinal matura-
tion.  
 
Figure 14. Transcriptional changes during retinal maturation.  
(A) Volcano plot of protein expression ratios between week 2 and week 3 in the mouse retina as 
a function of statistical significance (Student t-test p value ≤ 0.01). Proteins with no detectable 
signal in one of the subsets were assigned a ratio of infinity. (B) Gene ontology (GO) analysis of 
upregulated proteins during retinal maturation (from eye opening at week 2 to terminal maturation 
of the retina at week 3) identified by label free quantification (LFQ) proteomics.  
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3.2 Epigenetic changes during retinal maturation 
To study whether these transcriptional changes during retinal maturation are due to dif-
ferential DNA modification, global levels of 5-methylcytosine (5mC) and its oxidative 
derivatives 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxycy-
tosine (5caC) were quantified using high performance liquid chromatography coupled to 
tandem mass spectrometry (HPLC-MS/MS). 5mC levels remained stable during retinal 
maturation (p-value > 0.05, t-test) (Figure 15A). In contrast, the levels of 5hmC were 
significantly accumulating from week 2 to week 3 suggesting that 5hmC might be an 
important DNA modification during retinal maturation (p-value < 0.01, t-test) (Figure 
15B). Interestingly, the levels of 5fC dropped significantly during the respective time 
points (p-value < 0.001, t-test) (Figure 15C). Notably, 5caC was not detectable in both 
stages of retinal maturation, suggesting that either 5caC is a short-lived oxidative inter-
mediate or not generated during retinal maturation.  
 
 
Figure 15. Cytosine derivative levels during retinal maturation.  
 
Scatterplots of HPLC-MS/MS quantification of global (A) 5-methylcytosine (5mC), (B) 5-hy-
droxymethylcytosine (5hmC) and (C) 5-formylcytosine (5fC) in the mouse retina at week 2 and 
3 reveal an age-dependent increase in 5hmC levels, stable 5mC levels and decreasing 5fC levels. 
Summary data are mean ± SEM. ** p < 0.01, ** p < 0.001 (Student’s t-test).  
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3.3 Dynamics of 5hmC localization  
To study the localization of 5hmC during retinal maturation, a 5hmC-specific antibody 
was used for immunohistochemical studies on retinal cryosections. At eye opening (week 
2), the strongest 5hmC signal was observed in retinal ganglion cells that are present in the 
ganglion cell layer (GCL). Moreover, high 5hmC levels were present in the inner nuclear 
layer (INL) that is composed of the nuclei of amacrine cells, bipolar cells and horizontal 
cells. In contrast, the nuclei of rod and cone photoreceptor cells that exist in the outer 
nuclear layer (ONL) and are responsible for the detection of light stimuli were only faintly 
stained or immuno-negative (Figure 16A).  
In comparison to eye opening a stronger 5hmC immunosignal was observed in the gan-
glion cell layer and the inner nuclear layers of mature retina (week 3) (Figure 16B). No-
tably, cone and rod photoreceptors were also positive for 5hmC in the mature retina (Fig-
ure 16B), revealing dynamic 5hmC accumulation in the nuclei of photoreceptors during 
terminal photoreceptor differentiation. To confirm the specificity of the 5hmC antibody 
the immunosignal was quantitatively depleted using 2.5 µM 5hmC-containing DNA oli-
gonucleotides (inlay in Figure 16B).  
 
Figure 16. Immunosignal of 5hmC during retinal maturation.  
(A-B) Confocal scans from mouse retinal slices at week 2 (A) and week 3 (B) immunolabeled for 
5hmC (green). There is a marked increase in 5hmC signal in nuclei of all retinal layers from week 
2 to 3, in particular in photoreceptors (outer nuclear layer, ONL). The inlay image in (B) is from 
a depletion experiment proving the specificity of the anti-5hmC antibody. Scale bar marks 25 µm. 
In collaboration with Dr. Susanne Koch. 
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3.4 Subnuclear localization of 5hmC  
In conventional nuclei, present in most eukaryotic cells, heterochromatin (inactive chro-
matin) is located at the nuclear periphery and euchromatin (active chromatin) is present 
towards the nuclear interior.  Interestingly it was shown that the nuclei of rods in nocturnal 
retinas e.g. mouse retina remodel from a conventional nucleus to a unique inverted nu-
clear architecture, in which heterochromatin is localized in the nuclear center and euchro-
matin is present in the nuclear border during retinal maturation (Figures 17A) (Solovei et 
al. 2009).   
To gain insights in the potential epigenetic functions of 5hmC the subnuclear localization 
of 5hmC was studied during retinal maturation by costaining with heterochromatin asso-
ciated 5mC. Notably, 5hmC was predominantly present in euchromatic regions in con-
ventional nuclei as well as inverted rod nuclei. In contrast, 5mC was concentrated in pe-
ricentromeric heterochromatin (Figures 17B). This suggests that 5hmC could be impli-
cated in transcriptional activation of previously methylated and therefore transcriptionally 
repressed genes.  
 
Figure 17. Subnuclear localization of 5mC and 5hmC. 
(A) Schematic view of conventional and inverted nuclei depicting heterochromatin and euchro-
matin regions. (B) High magnification images of conventional nuclei within the ganglion cell 
layer (GCL) or the inner nuclear layer (INL) and a rod nucleus with inverted nuclear architecture 
(Solovei et al., 2009) co-immunolabeled with 5hmC (green) and 5mC (red). In all cases 5hmC is 
mainly found in euchromatin whereas 5mC is localized in heterochromatic regions. Scale bar in 
B marks 3 µm. 
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3.5  [methyl-13CD3]-L-methionine feeding  
Due to the fact that 5hmC is not co-localizing with its predecessor 5mC, two possibilities 
are imaginable. First pre-existing 5mC present in heterochromatin could be oxidized by 
Tet enzymes to de novo 5hmC leading to chromatin remodeling by recruitment of chro-
matin remodeling enzymes or repulsion of heterochromatin associated proteins that inter-
act with 5mC. Alternatively, de novo 5hmC could be generated from de novo methylation 
that occurs in euchromatic regions. To test those two hypotheses, the dynamics of 5hmC 
and 5mC generation during retinal maturation were investigated. Therefore, an isotope 
tracing experiment was performed by culturing retinal explants from 11-day-old mice in 
[methyl-13CD3]-L-methionine containing medium. The labeled methyl group donor 
[13CD3]-L-methionine is utilized by DNA methyltransferases for 5mC formation giving 
rise to labeled 5mC (5-[13CD3]-mC) and 5hmC (5-[
13CD2]-hmC) (Pfaffeneder et al., 
2014). After culturing for three, six and nine days the retinal cultures were harvested, the 
DNA was isolated and labeled 5mC and 5hmC was quantified using HPLC-MS/MS. Con-
firming the presence of de novo methylation in non-dividing retinal cells 5-[13CD3]-mC 
was detected at linearly increasing levels (slope: 0.531, R2=0.999) reaching a value of 3.9 
% of total 5mC after nine days of [13CD3]-methionine feeding (Figure 18A). [
13CD2]-
labeled 5hmC was also detected (Figure 18B). However, the level of 5-[13CD2]-hmC was 
low with only up to 1.6 % after nine days (slope: 0.208, R2=0.997). Notably, the amount 
of labeled 5-[13CD2]-hmC derived from nascent (labeled) 5mC accounted for 14-15 % of 
total de novo 5hmC whereas the unlabeled 5hmC generated from pre-existing (unlabeled) 
5mC corresponded to 85-86 % of total de novo 5hmC. Thus, the majority of de novo 
5hmC was generated from pre-existing and hence unlabeled 5mC (Figure 18C).  
 
Figure 18. Isotope tracing in mouse retinal explant cultures.  
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Retinal explant cultures were fed with [methyl-13CD3]-L-methionine and harvested for HPLC-
MS/MS quantification of labeled 5mC (A) and 5hmC (B) after 3, 6 and 9 days in vitro (DIV). (C) 
Stacked bar graph showing HPLC-MS/MS quantification of the absolute levels of 5hmC. Sum-
mary data in A and B are mean ± SD.  
 
 
 
3.6 Dnmt Expression levels 
Next, the dynamics of Dnmt expression levels was studied using reverse-transcription 
quantitative PCR (RT-qPCR) during retinal development. Interestingly, the levels of 
Dnmt1 dropped significantly from postnatal day 2 (p2) to later developmental stages and 
were lowest during retinal maturation (p13 to p20) (Figure 19A). Dnmt3b showed low 
expression levels relative to ESC and the showed lowest expression during retinal 
maturation (Figure 19B). In contrast Dnmt3a showed increased expression levels 
compared to ESC and showed highest expression during retinal maturation (Figure 19C). 
This data suggests that Dnmt3a could be mainly involved in de novo methyation during 
retinal maturation.  
 
 
Figure 19. Time course of Dnmt expression levels. 
(A-C) RT-qPCR analysis of Dnmt1 (A), Dnmt3b (B) and Dnmt3a (C) gene expression in mouse 
retina at postnatal day (p) 2, 11, 12, 13 and 20 normalized to corresponding mouse embryonic 
stem cell (ESC) levels. Summary data are mean ± SEM. 
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3.7  Genomic distribution of 5hmC during retinal maturation 
To further investigate the genomic localization and dynamics of 5hmC during retinal mat-
uration an antibody-based 5hmC DNA immunoprecipitation (hMeDIP) from 2- and 3-
week-old retina was performed followed by next-generation sequencing (NGS). This 
method allows mapping of 5hmC signal precisely to inter- or intragenic regions and de-
tection of differential 5hmC patterns during retinal maturation. 
In line with the immunohistochemical and HPLC-MS/MS quantification data higher lev-
els of 5hmC were detected at week 3 in comparison to week 2. Furthermore, the data 
revealed a dynamic change of 5hmC during retinal maturation. The hMeDIP data dis-
played an increase of 5hmC signal, mostly in intragenic regions, especially at promoters 
and gene bodies (Figure 20A). Next, the genes strongly enriched with intragenic 5hmC 
were studied. Interestingly, 5921 intragenic regions gained 5hmC, whereas 22 times less 
intragenic regions were detected with lost 5hmC signal and 511 regions conserved in their 
5hmC levels (Figure 20B).  
 
Figure 20. Differentially hydroxymethylated regions during retinal maturation.  
(A) Venn diagram showing 5hmC dynamics during retinal maturation (postnatal week 3 / post-
natal week 2). (B) Gene ontology analysis of genes gained that 5hmC during retinal maturation.  
 
Gene ontology (GO) analysis revealed that genes involved in the morphology of the nerv-
ous system, CNS development, differentiation of neurons, neuritogenesis or guidance of 
axons are significantly enriched within the group of genes that gained 5hmC after eye 
opening (from week 2 to 3) (Figure 21A). Correlation of the hMeDIP data with the LFQ 
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protein expression data showed a positive correlation of accumulation of 5hmC in genes 
with increased protein expression of the corresponding genes (p value < 0.005, t-test) 
(Figure 21B), suggesting a regulatory function of 5hmC in gene expression. 
 
 
Figure 21. Genomic localization of 5hmC and its effect on gene expression. 
(A) Pie chart showing intragenic distribution of 5hmC regions in mature retina. (B) Label free 
quantification (LFQ) of proteins encoded by genes with conserved (grey) or gained 5hmC levels 
(green) during retinal maturation. Summary data are mean ± standard error of mean (SEM). *** 
p < 0.001 (Student's t-test). TSS, transcription starting site; TTS, transcription termination site; 
UTR, untranslated region.  
 
 
 
3.8  Tet expression levels during retinal maturation 
Next, the transcriptional levels of Tet enzymes during retinal maturation were studied 
using RT-qPCR. Tet3 was the major isoform in the retina at every time point and showed 
up to 14-18 fold higher levels of expression from postnatal day 13 (p13) to postnatal day 
20 (p20) in comparison to Tet1. Importantly, the expression levels of Tet3 at eye opening 
(p13) and at the mature stage (p20) were comparable, ruling out that increased Tet ex-
pression causes the observed increase in 5hmC levels (Figure 22A).  
A recent study showed that TET3 exists in three isoforms that differ in their N-terminal 
sequence; two isoforms with a CXXC DNA-binding domain and a short isoform enriched 
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in neuronal cells lacking the CXXC domain (Liu et al., 2013a). Using isoform-specific 
primer sets the short variant lacking the CXXC domain was found to be the major Tet3 
isoform in the retina (Figure 22B).  
 
Figure 22. Tet expression levels during retinal maturation.  
(A) RT-qPCR analysis of Tet1, Tet2 and Tet3 gene expression in mouse retina at postnatal day 
(p) 2, 11, 12, 13 and 20 normalized to corresponding Tet1 levels. Tet3 is significantly higher 
expressed than Tet1 and Tet2 at p13 and p20. (B) RT-qPCR analysis of Tet3 isoforms. Tet3 lack-
ing a CXXC DNA binding domain (neuronal Tet3) is the main isoform in retina. Summary data 
are mean ± SEM. *** p < 0.001 (1-way ANOVA). 
 
 
 
3.9  Identification of neuronal TET3 interactors  
Other than the isoforms that contained a CXXC domain this neuronal TET3 variant did 
not have a DNA binding affinity (Xu et al., 2012) suggesting that unknown DNA binding 
(transcription) factors are necessary for binding and targeting this isoform to pre-existing 
5mC for targeted oxidation to 5mC (Figure 23). Therefore, interacting proteins of neu-
ronal TET3 were identified by combining affinity purification with mass spectrometry. 
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Figure 23. Schematic view of TET3 recruitment. 
Cartoon illustrating putative DNA binding mechanisms of TET3 isoforms lacking (neuronal 
TET3) or containing a CXXC domain.  
To purify interacting proteins that specifically interact with the specific TET3 isoform 
lacking a CXXC domain, lentiviral vectors were generated that expressed CMV-
TET3ΔCXXC-eGFP. Next, mouse retinal explant cultures were transduced with this len-
tiviral vector expressing an eGFP-fusion protein of the neuronal TET3. Control cultures 
were transduced with lentiviral vectors expressing eGFP only (LV-CMV-eGFP). After 
onset of expression, nuclear protein complexes were extracted, affinity-purified and sub-
sequently labeled with TMT 2-plex reagents in forward and reverse "label swap" experi-
ments for comparative quantification using LC-MS. 52 proteins were significantly en-
riched for binding to TET3 (> 1.5-fold enrichment) in forward and reverse labeling ex-
periments (proteins in the bottom-right quadrant in Figure 24) (see also Table 6). Notably, 
nine of those proteins, i.e. CEP290, CHD4, HMGN2, MAGI2, NOLC1, PLK2, REST, 
SPDEF and SUZ12 are known regulators of transcription. Another six proteins are his-
tone variants involved in chromatin modification e.g. HIST1H1C, H3F3A and H2AFJ 
(Figure 24).  
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Figure 24. Neuronal TET3 interacting proteins  
Scatterplot of TET3 interactors identified using lentiviral TET3-eGFP overexpression in retinal 
explant cultures followed by GFP-trap and LC-MS/MS.  
 
 
 
3.10 Identification of endogenous TET3 interactors  
In the experiment described in 3.9 TET3-eGFP is expected to compete for binding part-
ners with endogenous TET3. Thus, to gain a better understanding of endogenous TET3 
interaction partners, the affinity purification experiment was repeated on retinal lysates 
using a TET3-specific antibody. Importantly, endogenous TET3 was highly enriched in 
the forward and reverse experiment after antibody based purification highlighting its 
specificity (Figure 25A). Interestingly, three H3K36 methyltransferases (NSD2, NSD3 
and SETD2) were identified as TET3 interactors displaying a significant enrichment for 
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binding to endogenous TET3 (>1.5 fold) (Figure 25A). Furthermore, five transcriptional 
regulators i.e. ASXL1, CTCF, MORF4L1, REST and VAX1 were identified. Notably, 
the TET3-interacting protein with the highest enrichment score was the transcriptional 
repressor REST (Figure 25A), which was also significantly enriched in the TET3-eGFP 
affinity purification experiment (Figure 24). Therefore, the interaction of REST and 
TET3 was studied further. First, the interaction of TET3 with REST was validated by 
performing an affinity purification using a REST-specific antibody. Importantly, endog-
enous REST was highly enriched in the forward and reverse experiment by the antibody 
(Figure 25B). In line with the previous experiments the REST antibody affinity-purified 
TET3 very efficiently with the overall third-highest enrichment score, but neither im-
munoprecipitated TET1 nor TET2 (Figure 25B).  
 
 
Figure 25. Endogenous TET3-interacting proteins.  
(A) Heatmap of endogenous TET3 interaction partners identified by immunoprecipitation and 
LC-MS/MS. (B) Heatmap of endogenous REST immunopurification LC-MS/MS experiment 
confirming the interaction with endogenous TET3. (nd) not detected.  
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3.11  Functional characterization of TET3 binders 
To test whether the interaction of REST with TET3 had an effect on its hydroxylase ac-
tivity neuronal TET3 was overexpressed alone or together with REST in HEK293T cells. 
Subsequently, 5hmC levels were quantified using HPLC-MS/MS (Figure 4A). Non-trans-
fected HEK293T cells have very low endogenous 5hmC levels and overexpression of 
TET3-eGFP alone resulted in increased 5hmC levels. Interestingly, co-expression of 
REST with neuronal TET3 led to significantly higher levels of 5hmC (Figure 26A). To 
validate that REST regulates TET3 hydroxylase activity a siRNA mediated REST knock-
down approach was used. First knockdown efficiency of siRNA against REST was stud-
ied using RT-qPCR. Both siRNAs against REST showed a significant decrease in REST 
gene expression levels compared to the siRNA control (p-value < 0.01, t-test) (Figure 
26B). The siRNA REST #1 was used for subsequent studies. Next, a siRNA mediated 
knockdown of endogenous REST combined with neuronal TET3 overexpression was per-
formed in HEK293T cells. In line with the previous finding, a knockdown of REST lead 
to decreased 5hmC levels in comparison to control siRNA treatment (Figure 26C). In 
conclusion, REST is sufficient and necessary to control TET3 hydroxylase activity.  
 
 
Figure 26. Functional analysis of the interaction of REST and neuronal TET3  
HPLC-MS/MS quantification of global 5-hydroxymethylcytosine (5hmC) levels after overex-
pression (OE) of TET3-eGFP or REST and TET3-eGFP. (B) Both siRNAs efficiently reduced 
REST expression levels in HEK293T cells. Summary data are mean ± SEM. * p<0.05, ** p 
< 0.01, ** p <0.001 (Student’s t-test). (C) HPLC-MS/MS quantification of global 5hmC levels 
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after overexpression (OE) of TET3-eGFP in the presence of siRNA directed against human REST 
or a scrambled siRNA control (ctrl).  
 
 
 
3.12 TET3 induced changes in gene expression 
REST is a transcriptional repressor that binds to specific RE-1 binding sites present in 
regulatory regions of its target genes (Kraner et al., 1992). Binding of REST results in 
transcriptional repression of the corresponding genes (Chong et al., 1995; Schoenherr and 
Anderson, 1995). Thus, it is possible that TET3 mediated 5mC oxidation might affect 
gene expression of REST target genes. Thus, neuronal TET3 was overexpressed in 
HEK293T cells that endogenously contain REST (Dietrich et al., 2012) to investigate 
global protein level changes using LFQ proteomics (Figures 27A-C). 308 of the identified 
proteins were known REST targets (Lu et al., 2014). Importantly, the protein levels of 
those 308 REST targets were significantly elevated in the TET3 overexpression compared 
to the eGFP control experiment (Figure 27A). Importantly, 11 REST targets were signif-
icantly enriched in the group of 40 TET3-induced proteins (p = 1.6x10-6, Fischer's exact-
test) (Figure 27B). Overexpression of TET3-eGFP resulted in significant upregulation of 
26 previously non-expressed proteins (proteins with infinite log2 ratios in Figure 21C), 
and 6 of them were known REST target genes (LARS, MYH9, DDX39A, MCM4, RAB35 
and RBBP7) (Figure 27C).   
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Figure 27. Neuronal TET3 induced expression changes in HEK293T cells  
(A) Identification of global REST target gene expression using LFQ after eGFP (control) or 
TET3-eGFP overexpression in HEK293T cells. REST target genes are significantly higher ex-
pressed after TET3 OE. (B) Venn diagram showing the significant overlap (Fishers exact-test; p-
value = 1.6x10-6) of proteins enriched after TET3 OE and REST target genes in HEK293T cells. 
(C) Volcano plot of protein expression ratios between TET3eGFP and eGFP overexpression ex-
periments in HEK293T cells as a function of statistical significance (standard t-test p value ≤ 
0.01). Proteins with no statistically significant difference in expression between subsets are grey. 
Proteins with no detectable signal in one of the subsets were assigned a ratio of infinity. REST 
targets genes are highlighted in red. *** p < 0.001 (Student’s t-test).  
 
 
 
3.13 siRNA knockdown of REST and TET3 overexpression  
Next, the presence of REST on TET3-mediated induction of REST-target genes was in-
vestigated. Therefore, TET3-eGFP was overexpressed in the presence of REST-specific 
siRNA or scrambled control siRNA and the transcript levels of three selected REST-tar-
get genes (LARS, MCM4 and MYH9) were analyzed by comparing to the housekeeping 
gene ALAS using RT-qPCR. Interestingly, the TET3-mediated induction of expression of 
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those genes is significantly lower after knockdown of endogenous REST (Figure 28A-
C). 
 
Figure 28. Gene expression of three TET3-induced REST-target genes  
Quantification of three TET3-induced REST-target genes in HEK293T cells using RT-qPCR after 
overexpression (OE) of TET3-eGFP in the presence of siRNA directed against human REST 
(green) or a scrambled siRNA control (ctrl) (blue). Summary in (A-C and F) data are mean ± 
standard error of mean (SEM). * p < 0.05, ** p < 0.01 (Student's t-test).  
 
 
 
3.14 5hmC and REST co-localize in euchromatin 
The previous results suggest that REST directs TET3 to repressed target genes resulting 
in hydroxymethylation of 5mC. This goes along with de-repression and transcriptional 
activation of the respective genes. Transcriptionally inactive genes are largely found in 
heterochromatin, whereas actively transcribed genes are present in euchromatin. As 
shown in Figure 17B 5mC is enriched in heterochromatin whereas 5hmC is present in 
euchromatin. To test for the co-localization of REST with 5mC and 5hmC in nuclei of 
retinal neurons an in situ proximity ligation assay (PLA) was performed by combining a 
REST-specific antibody with 5mC or 5hmC-specific antibodies. PLA gives only a posi-
tive signal when 5mC or 5hmC and REST are in close proximity (< 40nm) (Soderberg et 
al., 2006). First, a positive PLA signal was detected for both antibody combinations (Fig-
ure 29A). The PLA signal of REST with 5mC was present in heterochromatin (Figure 29, 
left image), whereas the signal of REST with 5hmC was detected exclusively in euchro-
matin (Figure 29, right image). This suggests that REST-binding sites show distinct sub-
nuclear localization depending on the oxidation status of adjacent genomic cytosines. 
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Figure 29. PLA staining of 5mC / 5hmC and REST. 
(A) Proximity ligation assay (PLA) signal for 5mC and REST (upper panel) is localized in heter-
ochromatin. In contrast, the PLA signal for 5hmC and REST is localized in euchromatin (lower 
panel). Scale bar marks 1 µm. 
 
 
Interestingly, the levels of PLA signal for REST/5hmC and REST/5mC varied signifi-
cantly between week 2 and week 3 (Figure 30A-B). In particular, the REST/5hmC PLA 
signal correlated positively with the 5hmC levels increasing from week 2 to week 3 (Fig-
ure 30A). In contrast, the PLA signal for REST/5mC showed an inverse behavior during 
the same period of time (Figure 30B). Together, these results suggest a functional corre-
lation between REST binding sites and proximal epigenetic DNA marks that might affect 
chromatin state and gene expression. Next, the subset of genes that gained 5hmC marks 
from week 2 to week 3 (see Figure 20) were screened for known REST target genes (Lu 
et al., 2014). In support of a positive effect of REST on genomic 5hmC levels in the retina, 
a significant enrichment of REST-target genes within the group of genes that gained 
5hmC during retinal maturation was observed (p = 1.8x10-7, Fischer's exact-test) (Figure 
30C).  
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Figure 30. Accumulation of 5hmC is associated with chromatin remodeling  
(A-B) Quantification data of the 5mC/REST (B) and 5hmC/REST (C) PLA experiments shown 
in Figure 29. (C) Venn diagram showing the significant overlap (Fishers exact-test; p-value = 
1.8x10-7) of REST target genes and 5hmC gained genes during retinal maturation. * p < 0.05, *** 
p <0.001 (Student’s t-test). 
 
 
 
3.15 5hmC co-localizes with the active histone mark H3K36me3 
Transcriptional activation of previously silenced genes requires chromatin remodeling, 
e.g. a switch from a heterochromatic to a euchromatic state (Voss and Hager, 2014). It 
was suggested that REST mediated chromatin remodeling involves changes of the acti-
vating histone mark lysine 36 trimethylation of the nucleosomal histone H3 (H3K36me3) 
an epigenetic mark commonly associated with transcription of active chromatin 
(Bernstein et al., 2005; Heintzman et al., 2007; Kouzarides, 2007). To test for REST me-
diated chromatin remodeling the PLA signal of 5hmC with the active histone mark 
H3K36me3 was investigated during retinal maturation (Figure 31). 
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Figure 31. PLA staining of 5hmC and H3K36me3. 
PLA signal for 5hmC and H3K36me3 in nuclei of the inner nuclear layer (INL; upper panel) and 
the ganglion cell layer (GCL; lower panel) at week 2 (left) and week 3 (right). Scale bar marks 5 
µm. 
As shown in Figure 32 we observed a significant increase of the PLA signal of 5hmC 
with the H3K36me3 co-localization in nuclei of 3-week-old retina in comparison to week 
2 retina. Thus, from week 2 to 3 the chromatin structure in retinal nuclei changes towards 
co-localization of 5hmC with the H3K36me3.  
 
Figure 32. Quantification of PLA signal (5hmC/ H3K36me3). 
(B) Quantification data of the 5hmC/H3K36me3 PLA experiments shown in Figure 31. Summary 
data are mean ± standard error of mean (SEM). ** p < 0.01 (Student's t-test). 
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3.16 TET3 stimulates NSD3 for H3K36 trimethylation 
Interestingly, three of the identified endogenous TET3 interacting proteins were the post-
SET domain containing histone-lysine N-methyltransferases NSD3, NSD2 and SETD2 
(Figure 25A). These histone writers are involved in the (tri-) methylation of nucleosomal 
histone H3 at lysine 36 (H3K36).  
To further investigate the functional consequences of the interaction between TET3 and 
H3K36me3 methyltransferases a PLA experiment with HEK293T cells transfected with 
TET3 and/or the H3K36me3 methyltransferase was performed. The PLA signal studied 
was a product of the two enzymes 5hmC and H3K36me3, respectively. NSD3 overex-
pression did not result in any detectable PLA signal (Figure 33A-B), which is in line with 
the very low levels of 5hmC in HEK293T cells. TET3 overexpressing cells showed a low 
amount of PLA signals suggesting that 5hmC is not formed in close proximity to 
H3K36me3 (Figures 33A-B). In contrast, co-expression of TET3 and NSD3 resulted in a 
synergism and significantly increased the 5hmC/H3K36me3 PLA signal (Figures 33A-
B). Next, the global changes in H3K36 trimethylation were studied by acidic histone ex-
traction, H3 purification and subsequent quantification of K36me3 using isobaric labeling 
and MS (Figure 33C). The quantification data revealed a 40-fold increase of the levels of 
H3K36me3 in the HEK293T cells co-overexpressing TET3 and NSD3 compared to non-
transfected cells (Figure 33D). Overexpression of TET3 or NSD3 alone provided only an 
about 2-fold increase of the H3K36me3 activation mark (Figure 33D). In conclusion, 
TET3 has a synergistic effect on the lysine methyltransferase activity of NSD3.  
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Figure 33. Effect of TET3-mediated hydroxylation on chromatin structure.  
(A) PLA signal for 5hmC and H3K36me3 in HEK293T cells overexpressing TET3-eGFP (left 
panel) and TET3 + NSD3 (right panel). (B) Quantification data of the 5hmC/H3K36me3 PLA 
experiments shown in (A). (C) Scheme of TMT4 - plex isobaric labeling and LC-MS quantifica-
tion of H3 modifications. (D) Isobaric labeling LC-MS quantification of H3K36me3 in HEK293T 
cells overexpressing TET3, NSD3 or TET3 and NSD3 compared to non-transfected cells. Sum-
mary data are mean ± standard error of mean (SEM) in (B and D). * p < 0.05, *** p < 0.001 (1-
way ANOVA). Scale bar in (A) marks 5µm.  
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3.17 Effects of TET3 overexpression in retinal explants 
To analyze if TET3 overexpression has an effect on global gene expression in the retina 
we transduced retinal explant cultures with lentiviral vectors expressing TET3-eGFP. 
Compared to retinal explant cultures overexpressing eGFP only, we identified 981 pro-
teins that were upregulated after TET3-eGFP overexpression. The TET3-eGFP overex-
pression strongly affects gene expression in the retina resulting in upregulation of proteins 
involved in several neurological functions (Figure 34A). Correlation analysis again re-
vealed that known REST targets were significantly enriched in the subset of TET3-up-
regulated proteins (p = 2.1x10-10, Fischer's exact-test) (Figure 34B). 
To test whether TET3 has also a positive effect on lysine methyltransferase activity in the 
retina we transduced retinal explant cultures with TET3-eGFP or eGFP using lentiviral 
vectors and determined the levels of H3K36me3 using the same methodology. Overex-
pression of TET3-eGFP was able to elevate the levels of H3K36me3 by a factor of 3.8 
suggesting that TET3-mediated hydroxylation of 5mC in retinal cells results in activation 
of NSD3 or similar enzymes to induce H3K36 trimethylation (Figure 34C). The data in-
dicates that this involves at least in part REST-assisted, TET3-mediated oxidation of ge-
nomic 5mC and subsequent gene expression. 
 
 
Figure 34. TET3 overexpression leads to activation of neuronal genes  
(A) Gene ontology analysis reveals strong enrichment of neuronal proteins within the subset of 
proteins induced after TET3 OE in mouse retinal explants. (B) Venn diagram showing the signif-
icant overlap (Fishers exact-test; p-value = 2.1x10-10) of proteins enriched after TET3 OE and 
REST target genes. (C) Isobaric labeling LC-MS quantification of H3K36me3 in mouse retina 
after TET3-eGFP or eGFP (control) overexpression. Summary data are mean ± standard error of 
mean (SEM). * p < 0.05 (Student's t-test).  
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4. Discussion 
 
4.1 Active DNA demethylation during retinal maturation 
It was suggested that 5hmC functions as an intermediate in a TET enzyme catalyzed ac-
tive DNA demethylation process (Guo et al., 2011). In this study, it was shown that 5mC 
is oxidized by TET enzymes to 5hmC during terminal retinal maturation suggesting active 
DNA demethylation. However, 5hmC predominantly accumulated in the DNA during 
retinal maturation and was not a short-lived metabolic by-product of oxidative active 
DNA demethylation. These findings were in line with previous studies in neuronal tissue 
that showed 5hmC accumulation during neurogenesis and ageing (Szulwach et al., 2011). 
Confirming the stability of 5hmC in retinal neurons, the metabolic feeding experiments 
revealed that de novo 5hmC stably increased in retinal explants. Moreover, de novo 5fC 
or 5caC formation was not detected in the feeding experiments with [methyl-13CD3]-me-
thionine, suggesting that 5hmC is not further oxidized during terminal differentiation. 
Nevertheless, it cannot be ruled out that 5hmC is slowly oxidized or even directly re-
moved to cytosine to a low degree or 5hmC removal occurs over a longer time period.  
Interestingly, the further oxidized cytosine derivative 5fC showed an inverse pattern of 
5hmC and its levels decreased during retinal maturation. Furthermore, 5caC levels were 
below detection limit. Suggesting that 5fC and 5caC are short-lived DNA intermediates 
during retinal maturation involved in active DNA demethylation. A recent study showed 
that 5fC and 5caC are generated during DNA demethylation by TET1 in distinct promot-
ers for active gene transcription in ES cells (Neri et al., 2015). Furthermore, it is known 
that 5fC and 5caC levels negatively correlate with TDG levels, indicating TDG-medi-
ated excision of 5fC/ 5caC and subsequent BER. Assuming TET1 is mainly in charge of 
5fC formation, it is conceivable that 5fC removal outweighs its formation due to the fairly 
low TET1 levels in retinal neurons. Nevertheless, it would be interesting to map 5fC en-
riched genomic loci to distinguish whether it is an active DNA demethylation product or 
maybe a distinct epigenetic signal itself during retinal maturation. 
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4.2 Epigenetic role of 5hmC 
This study shows that approximately 1.7 % of all cytosines are hydroxymethylated, cor-
responding to around nine million 5hmC bases in mouse retina. This suggests that 5hmC 
has important functions in retinal neurons. However, the role of 5hmC in the DNA of 
mammalian tissue is still unknown. The data indicates that 5hmC patterns in neuronal 
cells are dissimilar to those in ES cells which are associated with high levels of TET1 and 
TET2 and low levels of TET3 (Xu et al., 2011). According to TAB sequencing data for 
ES cells, 5hmC is abundant at enhancers (p300 sites) and underrepresented in gene bodies 
(Yu et al., 2012). In contrast, cortical NPCs and neurons are characterized by low levels 
of 5hmC at p300 sites and by enrichment of 5hmC in gene bodies. In line with these 
studies, high levels of 5hmC in gene bodies and a strong increase of 5hmC levels during 
retinal maturation in retinal and neuronal genes are detected, suggesting a tissue and 
stage-specific role of 5hmC. Furthermore, deposition of 5hmC is associated with in-
creased gene expression. However, the exact purpose of 5hmC formation remains elusive. 
It is imaginable that 5hmC removes the repressive effects on transcription mediated by 
5mC. Another option could be that 5hmC destabilizes the DNA structure, thereby facili-
tating the opening of the double helix by the transcription machinery (Lopez et al., 2012; 
Pfeifer et al., 2013; Wanunu et al., 2011). Moreover, a recent study has shown that 5hmC 
can recruit specific binding proteins (readers) in a tissue specific manner (Spruijt et al., 
2013; Takai et al., 2014). It cannot be excluded that such 5hmC readers contribute to the 
observed TET3-mediated transcriptional activation during retinal maturation. It is possi-
ble that 5hmC repels 5mC readers that mediate transcriptional repression. Furthermore, 
5hmC could recruit other chromatin remodeling proteins that are important for transcrip-
tional activation. To further unravel the role of 5hmC in, it is important to investigate 
5hmC readers in retinal neurons (Figure 35). 
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Figure 35. Potential role of 5hmC in retinal neurons. 
5hmC is a rather stable epigenetic DNA base in retinal neurons. Furthermore, it is associated with 
transcriptional activation. It is possible that 5hmC recruits specific reader proteins or removes the 
repressive function of 5mC by repulsion of 5mC readers.   
 
 
 
4.3  TET-mediated 5hmC formation 
The data reveals that 5hmC accumulates especially in gene bodies of neuronal and retinal 
genes and is associated with increased gene transcription during retinal maturation.  These 
findings support previous studies that showed that accumulation of 5hmC is related to 
neuronal genes and associated with active transcription in neurons (Hahn et al., 2013; 
Mellen et al., 2012). Additionally, TET3 lacking a CXXC DNA binding domain was 
shown to be the main TET isoform in mouse retina. Furthermore, a comprehensive anal-
ysis of interacting proteins was performed revealing that TET3 interacts with the tran-
scriptional regulator REST but not with TET1 and TET2.  
Interestingly, REST was shown to be a master regulator of genes involved in neuronal 
maturation processes (McGann et al., 2014). However, Rest is known to be a transcrip-
tional repressor of neuronal genes in non-neuronal cells (Chen et al., 1998, Schoenherr et 
al., 1996). Moreover, REST was described to act as a repressor in cell commitment of 
retinal ganglion cells by preventing premature expression in retinal progenitor cells (Mao 
et al., 2011). This repressive function of REST is mediated by interaction with other pro-
teins such as mSin3a or CoRest1 to form REST repressor complexes (Huang et al., 1999; 
McGann et al., 2014; Naruse et al., 1999). In the REST-specific affinity purification from 
nuclear lysates of mouse retina, none of the known REST repressive complexes were 
identified. However, studies suggest that REST also plays a role in proper function of 
neuronal cells (Lu et al., 2014; Lunyak and Rosenfeld, 2005). For example, it was shown 
that REST functions as an activator of neuronal genes during neuronal maturation in the 
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presence of a small double stranded non-coding RNA corresponding to the NRSE/RE1 
REST binding sequence (Kuwabara et al., 2004). These findings suggest that REST’s 
mechanisms of action highly depend on interaction partners. In line with this hypothesis, 
the present study shows that REST binds and recruits TET3 for 5hmC formation in retinal 
neurons that subsequently results in induction of gene expression. In particular, REST 
regulates TET3 hydroxylase activity and REST target genes accumulate 5hmC during 
retinal maturation. Furthermore, overexpression of TET3 activates REST target genes.  
In support of these findings, a recent study showed that deletion of REST in mouse em-
bryonic stem cells (ESCs) lead to significant loss of genomic 5hmC levels in regulatory 
regions (Feldmann et al., 2013).  
Based on the 5hmC-mapping data approx. 9 % (521 out of 5921) of the genes that gained 
5hmC during retinal maturation were known REST target genes. Thus, although REST 
contributes significantly (p = 1.8 x 10-7, Fischer's exact-test) to context-specific 5hmC 
generation additional factors should exist for TET3 recruitment. In line with this,  several 
other transcriptional regulators interacting with TET3 such as ASXL1, CTCF, 
MORF4L1, SUZ12 and VAX1 were identified. It is tempting to speculate that these tran-
scription regulators could influence TET3 hydroxylase activity in a similar way as REST. 
For instance, it was shown that the insulator CTCF interacts with Tet enzymes and that 
depletion of CTCF in mouse ESCs and adipocytes leads to a significant loss of 5hmC in 
transcriptional enhancers (Dubois-Chevalier et al., 2015; Feldmann et al., 2013). How-
ever, CTCF does not to discriminate between the Tet isoforms, since it binds to TET1 
and TET2 (Dubois-Chevalier et al., 2015) as well as to TET3 (present study). 
In conclusion, REST and most probably additional DNA-binding transcriptional regula-
tors recruit TET3 to neuronal genes during retinal maturation to oxidize 5mC to 5hmC 
and activate their transcription.  
Transcriptional activation requires chromatin remodeling and DNA accessibility for the 
transcriptional machinery. Previous studies have shown translocation of genomic regions 
from 5mC-rich heterochromatin to 5hmC-rich euchromatin (Hahn et al., 2013; Mellen et 
al., 2012; Yamaguchi et al., 2013). This study reveals that TET3 interacts with several 
H3K36 methyltransferases i.e. NSD2, NSD3 and SETD2. Furthermore, it was shown that 
TET3 stimulates the activity of NSD3 to generate the activating histone mark H3K36me3 
in close proximity to 5hmC.  
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It is likely, that TET3 is also able to stimulate the activity of NSD2 and SETD2. Interest-
ingly previous studies have shown that TET2 and TET3 regulate OGlycNAcylation and 
H3K4 methylation by interacting with OGT and the SET1/COMPASS complex in ESC 
(Chen et al., 2013; Deplus et al., 2013). Suggesting that different mechanisms of TET 
mediated transcriptional activation exist in a cell type-dependent manner.  
 
The data reveals that the transcriptional repressor REST can facilitate the recruitment of 
TET3 to 5mC-containing transcriptionally inactive genes (Figure 21). This transcriptional 
regulator-induced and context-specific recruitment is followed by TET3-mediated oxida-
tion of 5mC to 5hmC. Subsequently, H3K36 methyltransferases induce chromatin remod-
eling to facilitate active transcription (Figure 26). The findings favour a model that in-
volves highly dynamic transcription factor-dependent DNA hydroxymethylation that 
supports retinal network maturation by context-specific gene activation. Accordingly, the 
metabolic feeding experiments showed that the majority of nascent 5hmC marks are gen-
erated from pre-existing 5mC supporting the idea of TET3-induced chromatin remodel-
ing.  
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5. Summary 
 
The 2-oxoglutarate and Fe (II)-dependent ten-eleven translocation (TET) enzymes can 
oxidize 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine 
(5fC) and 5-carboxycytosine (5caC). Thus, it was hypothesized that this could be a path-
way for active DNA demethylation. However, several studies have shown that 5hmC lev-
els accumulate especially in neurons suggesting a role as an epigenetic mark. Neverthe-
less, the mechanism controlling TET activity and the role of 5hmC are poorly understood. 
In particular, it is not known how the neuronal TET3 isoform lacking a DNA binding 
domain is targeted to the DNA. 
In this study, the role of 5hmC during retinal maturation by genome-wide mapping of 
5hmC in immature (postnatal week 2) and mature mouse retina (postnatal week 3) was 
studied and correlated with expression data. Furthermore, interaction partners of neuronal 
TET3, the main isoform in retinal neurons, were identified. 
5hmC accumulates during retinal maturation especially in retinal and neuronal genes. 
Furthermore, the accumulation of 5hmC is associated with increased transcription. 
Among the identified proteins the transcriptional repressor REST was identified as a 
highly enriched TET3-specific interactor. Interestingly, REST was able to enhance TET3 
hydroxylase activity. Furthermore, increased 5hmC levels were detected in REST target 
genes during retinal maturation and overexpression of TET3 activated transcription of 
REST-target genes. Moreover, NSD3 and two other histone methyltransferases were 
found to interact with TET3 that are able to mediate H3K36 trimethylation. Finally, it 
was shown that TET3 is able to enhance NSD3-mediated H3K36 trimethylation to pro-
mote transcriptional activation. 
In conclusion, the data suggests that 5hmC is a stable epigenetic base in retinal neurons 
that is involved in transcriptional activation. Furthermore, it was shown that 5hmC is 
generated by TET3 that is recruited to the DNA by transcriptional regulators such as 
REST in a context-specific manner (Figure 36).  
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Figure 36. Model for neuronal TET3 mediated transcriptional activation.  
TET3 is recruited to the DNA by transcriptional regulators like REST for context-specific 5mC 
hydroxylation. Subsequently, TET3 mediates H3K36 trimethylation by recruitment of histone 
writers such as NSD3. 
 
 
 
 
 
 
Summary 84 
 
 
 
Zusammenfassung 
 
Die Fe2+- und Ketoglutarat abhängigen ten-eleven translocation (TET) Enzyme können 
5-Methylcytosin (5mC) zu 5-Hydroxymethylcytosin (5hmC), 5-Formylcytosin (5fC) und 
5-Carboxycytosin (5caC) zu oxidieren. Es wurde vermutet, dass es sich bei diesem Oxi-
dationsprozess, um einen möglichen Mechanismus zur aktiven DNA Demethylierung 
handeln könnte. Jedoch weisen einige Studien darauf hin, dass 5hmC in Neuronen akku-
muliert und selbst als epigenetischer Faktor fungiert. Die Regulierung der TET Enzyme, 
sowie die exakte Rolle von 5hmC ist aber bisher unklar. Insbesondere die Rekrutierung 
der neuronal TET3 Isoform, die keine DNA Bindedomäne enthält, an die DNA zur Ge-
nerierung von 5hmC ist nicht bekannt. 
In dieser Arbeit wird die Rolle von 5hmC während der retinalen Entwicklung untersucht 
durch genomweite Analyse von 5hmC in noch unausgereiften (postnatale Woche 2), so-
wie ausdifferenzierten Mäuseretina (postnatale Woche 3) und  anschließend wurden diese 
Daten mit Expressionsdaten korreliert. Desweiteren wurden Interaktionspartner des neu-
ronalen TET3, der Hauptisoform in retinalen Neuronen, untersucht. 
Wir konnten feststellen, dass 5hmC während der retinalen Entwicklung insbesondere in 
retinalen und neuronalen Genen akkumuliert. Diese Akkumulation korrelierte positiv mit 
erhöhter Transkription der entsprechenden Gene. Desweiteren fanden wir heraus, dass 
neuronales TET3 unter anderem mit dem Transkriptionsregulator REST interagiert. Inte-
ressanterweise war REST im Stande die Hydroxylaseaktivität von TET3 zu erhöhen. Zu-
dem fanden wir erhöhte 5hmC Levels in REST Zielgenen und Überexpression von TET3 
führte zur erhöhten Transkription von REST Zielgenen. Wir fanden auch NSD3 und zwei 
weitere Histonmethyltransferases, als Interaktoren von TET3 und konnten zeigen dass 
TET3 die H3K36 Trimethylierung von NSD3 erhöht. 
Zusammenfassend, weisen unsere Daten darauf hin, dass 5hmC eine stabile epigenetische 
Base in retinalen Neuronen ist und eine wichtige Rolle spielt in transkriptioneller Akti-
vierung. Desweiteren zeigen wir, dass 5hmC von TET3 etabliert wird, das durch Tran-
skriptionsregulatoren, wie REST an die DNA rekrutiert wird zur kontext-spezifischen 
Hydroxymethylierung. Abschließend zeigen wir, dass TET3 die NSD3 gesteuerte  
H3K36 Trimethylierung stimuliert um aktive Transkription zu steigern. 
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Tables 
 
6.1 Primers 
 
primer sequence 
mTET1 _fwd TGAAGCTCAAACATCAACA 
mTET1 _rev GTACCTCCATCACAGTCAC 
mTET2 _fwd AGCGGAGCCCAAGAAAGCCA 
mTET2 _rev CGAAAGCTGCGGTTGTGCTGT 
mTET3 _fwd CCTGCGGTGCCTCCTTCTCC 
mTET3 _rev TCCGGAGCACCTCCTCCTCC 
mAlas1_fwd TCGCCGATGCCCATTCTTATC 
mAlas1_rev GGCCCCAACTTCCATCATCT 
Table 3. Primers used for RT-qPCR in mouse retina. 
  
 
 
primer sequence 
Neurog2_fwd CACCGGCAGTAACTAACCTG 
Neurog2_rev AAGTTAGCAGATCTCGGGGTC 
Olig2_fwd TCCTCCACGGGGCCCTCG 
Olig2_rev CTCAGTCCCCGCTGACAAGTGC 
Ddx20_fwd GGACAGCAACAAATGGTG 
Ddx20_rev ATTAAGACTGGCCTGAGC 
Gm525_fwd CCAGGACAGTTAACTTCTG 
Gm525_rev AGCCTGACCTGACCCAAG 
Opn1sw_fwd TGTCTCTCTCTCTTTCACAC 
Opn1sw_rev GCATTTCACAGCATCCC 
Rora_fwd GTTACTTTAAAAACGCTCTC 
Rora_rev TTTTAGTGTGTGCGAGAG 
Otx2_fwd CGTTTCCTCTACACACAC 
Otx2_rev AGTCATCCCAAAATACAGTG 
Table 4. Primers used for hMeDIP qPCR validation. 
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primer sequence 
REST_fwd CTTTGTCCTTACTCAAGTTCTCAG 
REST_rev ACCTGTCTTGCATGGCGGGTTA 
LARS_fwd CGTCGTTCCTTCATCACCACTG 
LARS_rev AGGCTGTCCATCTTTCGGAGAG 
MCM4_fwd CTTGCTTCAGCCTTGGCTCCAA 
MCM4_rev GTCGCCACACAGCAAGATGTTG 
MYH9_fwd ATCCTGGAGGACCAGAACTGCA 
MYH9_rev GGCGAGGCTCTTAGATTTCTCC 
Table 5. Primers used for RT-qPCR in HEK293T cells. 
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6.2 Lists of identified interaction partners 
 
gene name Description # peptides 
log2 
(IP/control) 
log2 
(control/IP) 
4930595M18Rik Protein 4930595M18Rik  14 0.78 -1.29 
4932431P20Rik Protein 4932431P20Rik  65 2.30 -2.61 
Ahsa2 
Activator of 90 kDa heat 
shock protein ATPase homo-
log 2 (Fragment)  
14 
0.77 -2.67 
Akd1 Protein Akd1 (Fragment)  6 0.85 -0.93 
Angpt1 Angiopoietin-1  30 5.39 -4.67 
Bace1 Beta-secretase 1 (Fragment)  76 5.43 -4.86 
BC005561 Protein BC005561  30 3.46 -3.17 
Cdc14b 
Dual specificity protein 
phphatase CDC14B  
4 
3.27 -4.77 
Cep290 Centromal protein of 290 kDa  23 1.99 -2.38 
Chd4 
Chromodomain-helicase-
DNA-binding protein 4  
29 
1.11 -1.69 
Ckmt2 
Creatine kinase S-type, mito-
chondrial  
5 
0.86 -2.51 
Col12a1 Collagen alpha-1(XII) chain  10 2.02 -2.99 
Col5a2 Collagen alpha-2(V) chain  12 1.90 -0.62 
Dlg4 
Disks large homolog 4 (Frag-
ment)  
4 
5.68 -4.80 
Dmd Dystrophin  25 3.50 -3.27 
Dnajc14 
DnaJ homolog subfamily C 
member 14  
4 
2.08 -1.18 
Dopey1 Isoform 5 of Protein dopey-1  17 1.74 -3.00 
Dsg3 Isoform 2 of Desmoglein-3  6 3.99 -3.65 
Fsip2 
Fibrous sheath-interacting 
protein 2  
22 
2.66 -1.51 
Gigyf2 
PERQ amino acid-rich with 
GYF domain-containing pro-
tein 2  
24 
2.18 -1.76 
Gm3760 
Protein D830030K20Rik 
(Fragment)  
68 
3.35 -4.12 
Gm7221 Protein Gm7221  5 3.43 -3.34 
H2afj Histone H2A.J  8 1.72 -3.55 
H3f3a Histone H3  9 2.19 -2.80 
Hist1h1c Histone H1.2  59 0.60 -0.61 
Hist1h1e Histone H1.4  41 1.08 -0.61 
Hist1h2bf Histone H2B type 1-F/J/L  11 2.07 -2.95 
Hist2h2bb Histone H2B type 2-B  11 2.10 -2.95 
Hist3h2a Histone H2A type 3  8 1.72 -3.60 
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Hmgn2 
Non-histone chromomal pro-
tein HMG-17  
6 
2.98 -3.35 
Jakmip2 MCG4624, isoform CRA_c  4 2.10 -2.70 
Kif20b 
Isoform 2 of Kinesin-like pro-
tein KIF20B  
10 
2.97 -4.33 
Magi2 
Isoform 4 of Membrane-asso-
ciated guanylate kinase, WW 
and PDZ domain-containing 
protein 2  
9 
1.09 -1.05 
Manf Armet protein  9 3.15 -5.63 
Neb Protein Neb  40 2.53 -2.70 
Nhsl1 
Isoform 3 of NHS-like protein 
1  
22 
1.20 -4.89 
Nolc1 Protein Nolc1  15 2.21 -2.01 
Pacrgl PACRG-like protein  5 1.06 -1.04 
Pitpnm3 
Isoform 2 of Membrane-asso-
ciated phphatidylinitol trans-
fer protein 3  
4 
1.75 -1.76 
Plk2 
Serine/threonine-protein ki-
nase PLK2  
4 
6.16 -4.50 
Ptcd1 
Pentatricopeptide repeat-con-
taining protein 1, mitochon-
drial  
221 
4.83 -4.87 
Rest 
RE1-silencing transcription 
factor  
7 
1.30 -0.78 
Rpl7a-ps10 MCG18601  16 5.11 -3.60 
Scn2a1 Protein Scn2a1  5 1.52 -2.35 
Spdef 
SAM pointed domain-con-
taining Ets transcription factor 
(Fragment)  
4 
2.67 -2.61 
Suz12 Polycomb protein Suz12  5 2.10 -2.70 
Syne1 Isoform 4 of Nesprin-1  104 4.88 -4.68 
Ttn Titin  104 2.73 -2.59 
Tyk2 
Non-receptor tyrine-protein 
kinase TYK2  
63 
6.34 -5.15 
Vps52 
Vacuolar protein sorting-asso-
ciated protein 52 homolog  
5 
1.40 -2.70 
Wdr66 Protein Wdr66  15 1.11 -2.85 
Table 6. TET3 interaction partners identified after TET3 overexpression. 
Lentiviral transduction of LV-CMV-TET3∆CXXC-eGFP in retinal explant cultures fol-
lowed by GFP-trap purification and TMT-labeling in retina.  
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gene name description # peptides 
log2 
(IP/control) 
log2 
(control/IP) 
     
Tet3 Methylcytosine dioxygenase TET3 7 5.71 -7.19 
Rest RE1-silencing transcription factor 8 6.30 -7.03 
H3f3a Histone H3 36 5.99 -6.74 
Nhsl1 Isoform 3 of NHS-like protein 1 56 5.71 -6.50 
Whsc1l1 
Histone-lysine N-methyltransferase 
NSD3 87 5.55 -6.47 
Ctcf Transcriptional repressor CTCF 59 3.45 -5.56 
Birc6 
Baculoviral IAP repeat-containing 
protein 6 26 2.46 -5.35 
C5orf42  
Uncharacterized protein C5orf42 
homolog 26 2.56 -4.43 
Asxl1 
Putative Polycomb group protein 
ASXL1 14 1.78 -4.43 
Gprasp1 
G-protein coupled receptor-associ-
ated sorting protein 1 14 2.72 -4.17 
C3orf20  
Uncharacterized protein C3orf20 
homolog 12 2.24 -3.64 
Kif3b Kinesin-like protein KIF3B 22 2.49 -3.51 
Setd2 Protein Setd2 26 3.34 -3.47 
Whsc1 
Histone-lysine N-methyltransferase 
NSD2 32 3.60 -3.24 
Vax1 
Isoform 2 of Ventral anterior home-
obox 1 11 7.10 -3.10 
Morf4l1 Mortality factor 4-like protein 1 57 4.92 -2.75 
Postn Isoform 4 of Periostin 15 3.31 -2.66 
Postn Periostin 8 3.31 -2.66 
Mdn1 Midasin 16 2.04 -2.61 
Trdn Protein Trdn 24 1.47 -2.51 
Spag5 Sperm-associated antigen 5 6 5.02 -2.41 
Lrba 
Isoform 3 of Lipopolysaccharide-re-
sponsive and beige-like anchor pro-
tein 13 1.96 -2.32 
Top2b DNA topoisomerase 2-beta 50 4.31 -2.13 
Trim9 
Isoform 6 of E3 ubiquitin-protein 
ligase TRIM9 5 5.50 -2.11 
Hydin Hydrocephalus-inducing protein 47 3.71 -2.07 
Kiaa1109 
Isoform 3 of Uncharacterized pro-
tein KIAA1109 16 1.83 -2.02 
Ttn Titin 419 2.90 -1.98 
Myo5a Unconventional myosin-Va 14 1.61 -1.95 
Ttn Titin 398 2.77 -1.94 
Mgea5 
Isoform 3 of Bifunctional protein 
NCOAT 7 1.25 -1.87 
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Abca1 
ATP-binding cassette sub-family A 
member 1 34 1.79 -1.79 
Polk DNA polymerase kappa 7 4.86 -1.72 
Lrrc71 
Leucine-rich repeat-containing pro-
tein 71 8 2.95 -1.72 
Tec 
Isoform 4 of Tyrosine-protein kinase 
Tec 17 4.68 -1.67 
Herc1 Protein Herc1 12 2.66 -1.65 
Atad5 
ATPase family AAA domain-con-
taining protein 5 16 3.38 -1.61 
Gm973 Protein Gm973 6 4.79 -1.61 
Zmynd8 Protein Zmynd8 9 3.20 -1.61 
Utrn Protein Utrn 18 1.61 -1.59 
Akd1 Protein Akd1 (Fragment) 15 2.52 -1.47 
Ctnna2 Isoform 2 of Catenin alpha-2 18 1.37 -1.47 
Dpysl2 
Dihydropyrimidinase-related protein 
2 8 2.61 -1.42 
Hkdc1 Putative hexokinase HKDC1 20 2.63 -1.27 
Akap13 Protein Akap13 46 4.31 -1.25 
Rbm19 Probable RNA-binding protein 19 23 2.08 -1.25 
Ttn Isoform 3 of Titin 25 3.31 -1.21 
Usp16 
Ubiquitin carboxyl-terminal hydro-
lase 16 18 2.00 -1.18 
Fsip2 Fibrous sheath-interacting protein 2 42 1.81 -1.17 
Gpatch8 G patch domain-containing protein 8 14 2.25 -1.14 
Prpf40b 
Pre-mRNA-processing factor 40 
homolog B (Fragment) 106 2.14 -1.14 
Trim67 
Tripartite motif-containing protein 
67 9 1.02 -1.14 
Eea1 Early endosome antigen 1 10 3.80 -1.11 
Vps13c 
Isoform 2 of Vacuolar protein sort-
ing-associated protein 13C 30 2.56 -1.02 
Afap1l1 
Actin filament-associated protein 1-
like 1 7 4.25 -1.01 
Dnah5 Dynein heavy chain 5, axonemal 22 2.97 -1.01 
 
Table 7. Endogenous TET3 interaction partners. 
Co-IP of endogenous TET3 followed by TMT-labeling in retina (postnatal week 3). 
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gene name description # peptides 
log2 
(IP/control) 
log2 
(control/IP) 
     
2700049A03Rik Protein 2700049A03Rik 30.00 5.14 -4.37 
Arfgef3 
Brefeldin A-inhibited gua-
nine nucleotide-exchange 
protein 3 
10.00 4.00 -1.83 
Atp5b 
ATP synthase subunit beta, 
mitochondrial 
26.00 5.29 -5.09 
Axdnd1 
Axonemal dynein light 
chain domain-containing 
protein 1 
84.00 5.92 -2.59 
Cbx2 
Chromobox protein homo-
log 2 
11.00 6.53 -3.19 
Col6a6 Collagen alpha-6(VI) chain 27.00 7.08 -2.98 
Ctcfl 
Transcriptional repressor 
CTCFL 
22.00 8.31 -4.97 
Cylc2 Protein Cylc2 24.00 3.78 -3.29 
Dennd4a Protein Dennd4a 23.00 8.03 -2.72 
Dhx29 
ATP-dependent RNA hel-
icase Dhx29 
51.00 5.42 -4.47 
Dnahc10 Protein Dnahc10 51.00 4.22 -4.79 
Dync1h1 
Cytoplasmic dynein 1 heavy 
chain 1 
33.00 7.35 -1.84 
Evpl Envoplakin 48.00 4.37 -3.78 
Fam217a Protein FAM217A 34.00 6.99 -5.24 
Fsip2 
Fibrous sheath-interacting 
protein 2 
64.00 4.16 -3.58 
Gcc2 
GRIP and coiled-coil do-
main containing 2 
38.00 3.79 -2.83 
Gcc2 
GRIP and coiled-coil do-
main-containing protein 2 
38.00 3.79 -2.83 
Gcn1l1 Protein Gcn1l1 54.00 4.13 -3.24 
Gm4945 Protein Gm4945 27.00 4.77 -3.86 
Gm5828 Uncharacterized protein 38.00 4.83 -3.15 
Gm973 Protein Gm973 117.00 4.08 -2.09 
Gnat3 
Guanine nucleotide-binding 
protein G(t) subunit alpha-3 
17.00 4.00 -3.34 
Grm8 
Metabotropic glutamate re-
ceptor 8 
7.00 8.09 -2.34 
H1f0 Histone H1.0 104.00 7.39 -4.57 
H1foo Histone H1oo 80.00 4.11 -3.81 
H2afv Histone H2A.V 51.00 4.33 -2.82 
H2afz Histone H2A.Z 45.00 4.33 -2.82 
H3f3a Histone H3 59.00 5.25 -3.29 
Hist1h1b Histone H1.5 125.00 5.71 -5.06 
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Hist1h1c Histone H1.2 234.00 6.06 -4.80 
Hist1h1d Histone H1.3 266.00 4.38 -4.86 
Hist1h1e Histone H1.4 180.00 4.71 -5.26 
Hist1h1t Histone H1t 40.00 4.17 -4.33 
Hist1h2aa Histone H2A 81.00 4.89 -1.88 
Hist1h2ab Histone H2A type 1 135.00 4.72 -2.69 
Hist1h2af Histone H2A type 1-F 139.00 5.07 -1.90 
Hist1h2ak Histone H2A type 1-K 113.00 4.89 -1.88 
Hist1h2ba Histone H2B type 1-A 52.00 5.28 -4.83 
Hist1h2bb Histone H2B type 1-B 75.00 5.75 -5.23 
Hist1h2bf Histone H2B type 1-F/J/L 77.00 5.28 -5.30 
Hist1h2bm Histone H2B type 1-M 77.00 5.28 -5.30 
Hist1h2bp Histone H2B type 1-P 75.00 5.51 -5.23 
Hist2h2aa1 Histone H2A type 2-A 127.00 4.89 -2.82 
Hist2h2ac Histone H2A type 2-C 101.00 5.02 -2.82 
Hist2h2bb Histone H2B type 2-B 79.00 5.28 -5.30 
Hist2h2be Histone H2B type 2-E 61.00 5.28 -5.33 
Hist3h2bb Histone H2B type 3-B 61.00 5.28 -5.33 
Hk1 Hexokinase-1 21.00 7.03 -3.42 
Hk1 
Isoform HK1-SB of Hexoki-
nase-1 
21.00 7.03 -3.42 
Hnrnpa2b1 
Isoform 3 of Heterogeneous 
nuclear ribonucleoproteins 
A2/B1 
23.00 5.11 -4.09 
Kdm6b 
Lysine-specific demethylase 
6B 
59.00 6.99 -5.24 
Kiaa1109 
Isoform 6 of Uncharacter-
ized protein KIAA1109 
27.00 6.42 -4.45 
Lama1 Laminin subunit alpha-1 24.00 5.97 -2.49 
Lamb1 Laminin subunit beta-1 21.00 5.15 -5.28 
Map1a 
Microtubule-associated pro-
tein 1A 
64.00 6.95 -2.81 
Naca 
Nascent polypeptide-associ-
ated complex subunit alpha, 
muscle-specific form 
54.00 5.82 -5.44 
Nemf 
Nuclear export mediator fac-
tor Nemf 
69.00 5.34 -5.76 
Nfx1 
Transcriptional repressor 
NF-X1 
27.00 8.12 -6.13 
Pclo Isoform 2 of Protein piccolo 55.00 3.90 -3.66 
Pik3cg 
Phosphatidylinositol 4,5-
bisphosphate 3-kinase cata-
lytic subunit gamma isoform 
13.00 3.74 -2.43 
Plcb1 
Isoform B of 1-phosphati-
dylinositol 4,5-bisphosphate 
phosphodiesterase beta-1 
29.00 6.25 -4.54 
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Plcb2 
1-phosphatidylinositol 4,5-
bisphosphate phos-
phodiesterase beta-2 
33.00 7.72 -2.28 
Pold3 
DNA polymerase delta sub-
unit 3 
31.00 7.46 -3.32 
Pxk 
Isoform 2 of PX domain-
containing protein kinase-
like protein 
46.00 4.11 -2.91 
Rest 
RE1-silencing transcription 
factor 
53.00 8.62 -6.50 
Rpl29 60S ribosomal protein L29 36.00 4.14 -3.86 
Rrp15 RRP15-like protein 25.00 4.01 -5.42 
Scml2 Protein Scml2 19.00 4.91 -4.52 
Sh3tc1 Protein Sh3tc1 (Fragment) 32.00 5.54 -5.07 
Sos2 Son of sevenless homolog 2 20.00 8.58 -3.97 
Srebf1 
Isoform SREBP-1C-W42 of 
Sterol regulatory element-
binding protein 1 
6.00 8.78 -4.78 
Suclg2 
Isoform 2 of Succinyl-CoA 
ligase [GDP-forming] subu-
nit beta, mitochondrial 
30.00 4.93 -3.16 
Syt4 Synaptotagmin-4 22.00 7.76 -6.61 
TET3 
Methylcytosine dioxygenase 
TET3 
11.00 6.46 -6.64 
Tln1 Talin-1 79.00 3.90 -4.81 
Tma7 
Translation machinery-asso-
ciated protein 7 
31.00 4.47 -5.98 
Tnxb Protein Tnxb 27.00 6.05 -2.77 
Top2a DNA topoisomerase 2-alpha 42.00 4.00 -2.76 
Tox4 
TOX high mobility group 
box family member 4 
40.00 4.83 -3.15 
Traf3ip3 
TRAF3-interacting JNK-ac-
tivating modulator 
25.00 4.44 -2.22 
Ttn Titin (Fragment) 87.00 4.67 -2.42 
Tyk2 
Non-receptor tyrosine-pro-
tein kinase TYK2 
64.00 7.02 -5.29 
Usp53 
Inactive ubiquitin carboxyl-
terminal hydrolase 53 
20.00 5.80 -6.61 
Uty Histone demethylase UTY 12.00 6.93 -4.61 
Table 8. Endogenous REST interaction partners. 
Co-IP of endogenous REST followed by TMT-labeling in retina (postnatal week 3). 
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